MongoDB v poslední obchodní seanci klesl o 4,95 % na 312,33 USD a za měsíc odepsal 1,25 %. Investoři čekají na výsledky, kde trh počítá s EPS 1,6 USD a tržbami 733,61 mil. USD.
MongoDB (MDB - Free Report) closed the most recent trading day at $312.33, moving -4.95% from the previous trading session. The stock's performance was behind the S&P 500's daily loss of 1.01%. Meanwhile, the Dow lost 0.77%, and the Nasdaq, a tech-heavy index, lost 1.4%.
The database platform's stock has dropped by 1.25% in the past month, exceeding the Computer and Technology sector's loss of 3.73% and lagging the S&P 500's gain of 0.32%.
Investors will be eagerly watching for the performance of MongoDB in its upcoming earnings disclosure. The company is expected to report EPS of $1.6, up 60% from the prior-year quarter. Simultaneously, our latest consensus estimate expects the revenue to be $733.61 million, showing a 24.05% escalation compared to the year-ago quarter.
For the full year, the Zacks Consensus Estimates are projecting earnings of $6.07 per share and revenue of $2.94 billion, which would represent changes of +22.13% and +19.5%, respectively, from the prior year.
Investors should also pay attention to any latest changes in analyst estimates for MongoDB. Recent revisions tend to reflect the latest near-term business trends. As a result, we can interpret positive estimate revisions as a good sign for the business outlook.
Our research shows that these estimate changes are directly correlated with near-term stock prices. To utilize this, we have created the Zacks Rank, a proprietary model that integrates these estimate changes and provides a functional rating system.
The Zacks Rank system, running from #1 (Strong Buy) to #5 (Strong Sell), holds an admirable track record of superior performance, independently audited, with #1 stocks contributing an average annual return of +25% since 1988. Within the past 30 days, our consensus EPS projection remained stagnant. Currently, MongoDB is carrying a Zacks Rank of #3 (Hold).
In terms of valuation, MongoDB is currently trading at a Forward P/E ratio of 54.11. This expresses a premium compared to the average Forward P/E of 20.37 of its industry.
Investors should also note that MDB has a PEG ratio of 4.44 right now. Comparable to the widely accepted P/E ratio, the PEG ratio also accounts for the company's projected earnings growth. By the end of yesterday's trading, the Internet - Software industry had an average PEG ratio of 1.11.
The Internet - Software industry is part of the Computer and Technology sector. This industry currently has a Zacks Industry Rank of 86, which puts it in the top 35% of all 250+ industries.
The Zacks Industry Rank gauges the strength of our industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Make sure to utilize Zacks.com to follow all of these stock-moving metrics, and more, in the coming trading sessions.
Ralph Lauren (RL - Free Report) ended the recent trading session at $380.45, demonstrating a -1.97% change from the preceding day's closing price. This change lagged the S&P 500's daily loss of 1.01%. Elsewhere, the Dow saw a downswing of 0.77%, while the tech-heavy Nasdaq depreciated by 1.4%.
The stock of upscale clothing company has fallen by 6.03% in the past month, lagging the Consumer Discretionary sector's gain of 1.27% and the S&P 500's gain of 0.32%.
The upcoming earnings release of Ralph Lauren will be of great interest to investors. The company is expected to report EPS of $4.26, up 13% from the prior-year quarter. Meanwhile, the latest consensus estimate predicts the revenue to be $1.86 billion, indicating a 8.25% increase compared to the same quarter of the previous year.
For the annual period, the Zacks Consensus Estimates anticipate earnings of $18.33 per share and a revenue of $8.66 billion, signifying shifts of +10.49% and +6.68%, respectively, from the last year.
Any recent changes to analyst estimates for Ralph Lauren should also be noted by investors. These latest adjustments often mirror the shifting dynamics of short-term business patterns. Therefore, positive revisions in estimates convey analysts' confidence in the business performance and profit potential.
Our research suggests that these changes in estimates have a direct relationship with upcoming stock price performance. To benefit from this, we have developed the Zacks Rank, a proprietary model which takes these estimate changes into account and provides an actionable rating system.
The Zacks Rank system, stretching from #1 (Strong Buy) to #5 (Strong Sell), has a noteworthy track record of outperforming, validated by third-party audits, with stocks rated #1 producing an average annual return of +25% since the year 1988. Over the past month, there's been no change in the Zacks Consensus EPS estimate. Ralph Lauren is holding a Zacks Rank of #3 (Hold) right now.
Valuation is also important, so investors should note that Ralph Lauren has a Forward P/E ratio of 21.17 right now. This valuation marks a premium compared to its industry average Forward P/E of 16.56.
One should further note that RL currently holds a PEG ratio of 1.93. The PEG ratio bears resemblance to the frequently used P/E ratio, but this parameter also includes the company's expected earnings growth trajectory. The Textile - Apparel industry currently had an average PEG ratio of 2.31 as of yesterday's close.
The Textile - Apparel industry is part of the Consumer Discretionary sector. At present, this industry carries a Zacks Industry Rank of 187, placing it within the bottom 24% of over 250 industries.
The Zacks Industry Rank assesses the strength of our separate industry groups by calculating the average Zacks Rank of the individual stocks contained within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Keep in mind to rely on Zacks.com to watch all these stock-impacting metrics, and more, in the succeeding trading sessions.
Regions Financial Corp. reported continued growth in customers’ digital usage and transactions during the second quarter, with President, CEO and Chairman John M. Turner highlighting its online banking and mobile app offerings as “key initiatives that are central to our long-term strategy.”
Speaking during a Friday (July 17) earnings call, Turner said surveys ranked Regions No. 1 among regional banks in online banking satisfaction and No. 1 among regional banks in its mobile app.
“These results reflect the work we’ve done to enhance the client experience, deliver more intuitive digital capabilities and make banking easier for our customers,” Turner said.
Regions serves customers across the South, Midwest and Texas, according to its website. Its Regions Bank subsidiary operates 1,200 banking offices and 1,750 ATMs, per a recent press release.
Regions launched a new native mobile app and found that customers’ usage of Zelle increased by 44% compared to two years ago and that customer chat volume leapt 70% year over year, according to a presentation released Friday.
Over the past two years, Regions’ mobile banking active users increased 6% to 2.73 million, its mobile banking logins rose 19% to 211 million, and its share of customer transactions that were digital rose from 75% to 80%, per the presentation.
Regions continued its core modernization efforts during the second quarter, completing a successful implementation of a new commercial lending platform and making good progress on a core deposit transformation that is set to reach a pilot phase later this year and full conversion in 2027, Turner said during the call.
Of the commercial lending platform, Turner said: “This represents a significant step forward in enhancing our technology infrastructure, improving speed to market and elevating the experience we deliver to our clients and bankers.”
Surveying the overall operating environment, Turner said during the call that it remains encouraging and that it is supporting continued momentum in Regions’ core business.
“Economic activity is solid, and despite ongoing uncertainty, businesses are generally well positioned, and we continue to see steady levels of investment and job growth across our markets,” Turner said. “On the consumer side, spending trends remain health and customers maintain solid account balances and liquidity buffers relative to their spending levels with overall financial conditions remaining stable.”
On July 2, days after the end of the second quarter, Regions announced that it expanded its services by acquiring The Frazer Lanier Company, a Montgomery, Alabama-based full-service investment banking firm specializing in municipal and corporate securities.
Turner said during Friday’s call: “We believe this transaction expands our capital markets platform, enhances our municipal finance expertise and allows us to broaden the solutions we provide to the public sector and institutional clients.”
Brinker International uzavřela na 189,35 USD, tedy o 2,09 % výše než předchozí den, zatímco širší trh klesal. Před výsledky se očekává EPS 3,09 USD a tržby 1,53 miliardy USD.
In the latest trading session, Brinker International (EAT - Free Report) closed at $189.35, marking a +2.09% move from the previous day. This move outpaced the S&P 500's daily loss of 1.01%. Elsewhere, the Dow lost 0.77%, while the tech-heavy Nasdaq lost 1.4%.
The stock of operator of restaurant chains Chili's Grill & Bar and Maggiano's Little Italy has risen by 12.48% in the past month, leading the Retail-Wholesale sector's gain of 0.78% and the S&P 500's gain of 0.32%.
The upcoming earnings release of Brinker International will be of great interest to investors. It is anticipated that the company will report an EPS of $3.09, marking a 24.1% rise compared to the same quarter of the previous year. Our most recent consensus estimate is calling for quarterly revenue of $1.53 billion, up 4.7% from the year-ago period.
In terms of the entire fiscal year, the Zacks Consensus Estimates predict earnings of $10.75 per share and a revenue of $5.81 billion, indicating changes of +20.79% and +7.89%, respectively, from the former year.
It's also important for investors to be aware of any recent modifications to analyst estimates for Brinker International. These revisions help to show the ever-changing nature of near-term business trends. As a result, we can interpret positive estimate revisions as a good sign for the business outlook.
Our research demonstrates that these adjustments in estimates directly associate with imminent stock price performance. To benefit from this, we have developed the Zacks Rank, a proprietary model which takes these estimate changes into account and provides an actionable rating system.
The Zacks Rank system, ranging from #1 (Strong Buy) to #5 (Strong Sell), possesses a remarkable history of outdoing, externally audited, with #1 stocks returning an average annual gain of +25% since 1988. Over the last 30 days, the Zacks Consensus EPS estimate has witnessed a 0.13% increase. Brinker International presently features a Zacks Rank of #2 (Buy).
With respect to valuation, Brinker International is currently being traded at a Forward P/E ratio of 14.91. This denotes a discount relative to the industry average Forward P/E of 20.78.
We can also see that EAT currently has a PEG ratio of 1.15. The PEG ratio is similar to the widely-used P/E ratio, but this metric also takes the company's expected earnings growth rate into account. The Retail - Restaurants industry currently had an average PEG ratio of 2 as of yesterday's close.
The Retail - Restaurants industry is part of the Retail-Wholesale sector. This industry, currently bearing a Zacks Industry Rank of 188, finds itself in the bottom 24% echelons of all 250+ industries.
The Zacks Industry Rank assesses the vigor of our specific industry groups by computing the average Zacks Rank of the individual stocks incorporated in the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
To follow EAT in the coming trading sessions, be sure to utilize Zacks.com.
EURC od začátku roku zhruba zdvojnásobil tržní kapitalizaci z asi 205 milionů USD na kolem 430 milionů USD. Jeho podíl na trhu euro stablecoinů vzrostl zhruba z 17 % před rokem na více než 40 %.
Circle’s euro-backed stablecoin EURC has roughly doubled in market capitalization since the start of the year, climbing from approximately $205 million to around $430 million. The token’s circulation now sits at approximately €378 million as of mid-July, with its share of the euro stablecoin market ballooning from about 17% a year ago to north of 40%.
MiCA did the heavy lifting MiCA’s full enforcement in late 2024 and early 2025 created a compliance gauntlet that most euro stablecoin issuers couldn’t survive. The most notable casualty was Tether’s EURT, which exited the market rather than meet the new regulatory requirements.
Advertisement
Circle secured a French Electronic Money Institution license back in 2024, giving it a single regulatory passport to operate across the entire EU and European Economic Area. The supply numbers tell the story cleanly. EURC’s token supply grew from roughly 309 million at the end of 2025 to approximately 390 million in early 2026, nearly tripling in a compressed timeframe.
Multi-chain expansion and Base launch Circle has been deploying EURC across multiple blockchain networks, including Ethereum and Solana. The most recent expansion landed on July 9, when EURC went live on Coinbase’s Base network.
Daily active addresses for EURC hit an all-time high of 1,760 shortly after the Base launch. The broader euro stablecoin market has reached record highs approaching $900 million as of mid-2026, with EURC commanding roughly 40–50% of that total.
What this means for investors The institutional character of this growth is worth noting. The supply expansion and market cap gains appear driven by enterprise-level integrations rather than grassroots consumer adoption. The company has reportedly been building payment integrations with partners like Visa and exploring point-of-sale terminal support through Ingenico, which would push EURC into physical retail environments.
With the overall euro stablecoin market still under $1 billion, it remains a fraction of the dollar stablecoin market, which is measured in the hundreds of billions.
Disclosure: This article was edited by Editorial Team. For more information on how we create and review content, see our Editorial Policy.
Cava Group uzavřela seanci na 68,85 USD, což znamenalo růst o 1,1 % během dne, zatímco S&P 500 klesl o 1,01 %. Předtím akcie zaostávaly a za poslední období ztratily 23,64 %.
Cava Group (CAVA - Free Report) ended the recent trading session at $68.85, demonstrating a +1.1% change from the preceding day's closing price. This move outpaced the S&P 500's daily loss of 1.01%. On the other hand, the Dow registered a loss of 0.77%, and the technology-centric Nasdaq decreased by 1.4%.
Prior to today's trading, shares of the Mediterranean restaurant chain had lost 23.64% lagged the Retail-Wholesale sector's gain of 0.78% and the S&P 500's gain of 0.32%.
Investors will be eagerly watching for the performance of Cava Group in its upcoming earnings disclosure. The company is forecasted to report an EPS of $0.17, showcasing a 6.25% upward movement from the corresponding quarter of the prior year. Alongside, our most recent consensus estimate is anticipating revenue of $353.73 million, indicating a 26.06% upward movement from the same quarter last year.
For the full year, the Zacks Consensus Estimates are projecting earnings of $0.55 per share and revenue of $1.49 billion, which would represent changes of +1.85% and +26.2%, respectively, from the prior year.
It's also important for investors to be aware of any recent modifications to analyst estimates for Cava Group. These latest adjustments often mirror the shifting dynamics of short-term business patterns. Hence, positive alterations in estimates signify analyst optimism regarding the business and profitability.
Our research demonstrates that these adjustments in estimates directly associate with imminent stock price performance. Investors can capitalize on this by using the Zacks Rank. This model considers these estimate changes and provides a simple, actionable rating system.
The Zacks Rank system, which ranges from #1 (Strong Buy) to #5 (Strong Sell), has an impressive outside-audited track record of outperformance, with #1 stocks generating an average annual return of +25% since 1988. Over the last 30 days, the Zacks Consensus EPS estimate has remained unchanged. Currently, Cava Group is carrying a Zacks Rank of #3 (Hold).
Valuation is also important, so investors should note that Cava Group has a Forward P/E ratio of 124.95 right now. This indicates a premium in contrast to its industry's Forward P/E of 20.78.
We can also see that CAVA currently has a PEG ratio of 4.67. The PEG ratio is similar to the widely-used P/E ratio, but this metric also takes the company's expected earnings growth rate into account. The Retail - Restaurants industry had an average PEG ratio of 2 as trading concluded yesterday.
The Retail - Restaurants industry is part of the Retail-Wholesale sector. This industry, currently bearing a Zacks Industry Rank of 188, finds itself in the bottom 24% echelons of all 250+ industries.
The Zacks Industry Rank gauges the strength of our industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
To follow CAVA in the coming trading sessions, be sure to utilize Zacks.com.
Coca-Cola při posledním uzavření klesla o 3,96 % na 81,56 USD, tedy výrazně víc než S&P 500, který ztratil 1,01 %. Investoři čekají na hospodářské výsledky 28. července 2026.
In the latest close session, Coca-Cola (KO - Free Report) was down 3.96% at $81.56. This change lagged the S&P 500's daily loss of 1.01%. At the same time, the Dow lost 0.77%, and the tech-heavy Nasdaq lost 1.4%.
The world's largest beverage maker's stock has climbed by 6.97% in the past month, exceeding the Consumer Staples sector's gain of 1.62% and the S&P 500's gain of 0.32%.
Market participants will be closely following the financial results of Coca-Cola in its upcoming release. The company plans to announce its earnings on July 28, 2026. It is anticipated that the company will report an EPS of $0.92, marking a 5.75% rise compared to the same quarter of the previous year. In the meantime, our current consensus estimate forecasts the revenue to be $13.05 billion, indicating a 4.15% growth compared to the corresponding quarter of the prior year.
For the full year, the Zacks Consensus Estimates project earnings of $3.26 per share and a revenue of $49.29 billion, demonstrating changes of +8.67% and +2.92%, respectively, from the preceding year.
Investors should also note any recent changes to analyst estimates for Coca-Cola. Recent revisions tend to reflect the latest near-term business trends. Consequently, upward revisions in estimates express analysts' positivity towards the business operations and its ability to generate profits.
Research indicates that these estimate revisions are directly correlated with near-term share price momentum. Investors can capitalize on this by using the Zacks Rank. This model considers these estimate changes and provides a simple, actionable rating system.
The Zacks Rank system, running from #1 (Strong Buy) to #5 (Strong Sell), holds an admirable track record of superior performance, independently audited, with #1 stocks contributing an average annual return of +25% since 1988. Over the last 30 days, the Zacks Consensus EPS estimate has witnessed an unchanged state. Right now, Coca-Cola possesses a Zacks Rank of #3 (Hold).
Digging into valuation, Coca-Cola currently has a Forward P/E ratio of 26.04. This signifies a premium in comparison to the average Forward P/E of 20.46 for its industry.
One should further note that KO currently holds a PEG ratio of 3.39. This metric is used similarly to the famous P/E ratio, but the PEG ratio also takes into account the stock's expected earnings growth rate. As the market closed yesterday, the Beverages - Soft drinks industry was having an average PEG ratio of 2.24.
The Beverages - Soft drinks industry is part of the Consumer Staples sector. With its current Zacks Industry Rank of 78, this industry ranks in the top 32% of all industries, numbering over 250.
The strength of our individual industry groups is measured by the Zacks Industry Rank, which is calculated based on the average Zacks Rank of the individual stocks within these groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Be sure to follow all of these stock-moving metrics, and many more, on Zacks.com.
Tesla čeká na výsledky s důrazem na CapEx a marže; Alphabet bude klíčově sledován přes tržby Google Cloud. Obě firmy mají pro kvartál vyšší odhady zisku i tržeb.
Key Takeaways The 2026 Q2 earnings season is in full swing, with a flurry of companies on deck to report soon. TSLA and GOOGL help headline the upcoming docket, with each seeing contrasting share performances in 2026. Google Cloud results are key for Alphabet, whereas Tesla's CapEx and margin performance remain critical. The 2026 Q2 earnings season is in full swing following the release of the big banks’ results, with many other notable companies on deck in the coming days and weeks.
Concerning next week’s docket, several Mag 7 members, Tesla (TSLA - Free Report) and Alphabet (GOOGL - Free Report) , are scheduled to report.
Watch Tesla’s CapEx and Margin PerformanceTesla shares haven’t had a strong showing in 2026 so far, down roughly 15% and underperforming and facing mixed post-earnings reactions. Its results in 2026 have been largely positive from an expectations standpoint, exceeding the Zacks Consensus EPS estimate by double-digit percentages in back-to-back prints.
Both EPS and sales expectations have trended higher over recent months, a bullish development as the company gears up to release its results. Earnings are forecasted to climb 22% YoY, whereas revenue is forecasted to see a 12% YoY climb.
Image Source: Zacks Investment Research
Margins have always been a key metric to watch for Tesla, which have largely dictated its price action overall. Its gross margin on a trailing twelve-month basis has recently turned higher after periods of decline, with continued improvement likely to drive significant overall positivity.
Image Source: Zacks Investment Research
It's also just as critical to rememer that Tesla is entering a massive, heavy-spending cycle, recently raising its 2026 CapEx forecast from $20 billion to over $25 billion. The huge spending levels are primarily aimed at constructing the computational and physical infrastructure needed for its real-world AI initiatives, including data centers to power FSD, the Robotaxi network, and more.
Google Cloud Results Remain KeyAlphabet shares have delivered a return on par with the S&P 500 so far in 2026, up roughly 10% and seeing huge positivity following the latest set of quarterly results. Alphabet has overall continued its stellar earnings track record in 2026, beating both EPS and revenue expectations in each 2026 release so far.
Like TSLA, Alphabet has seen bullish EPS and sales revisions for the quarter to be reported over recent months, but the revisions as of late have been more stable than anything. Though there haven’t been upward revisions recently, the stability here is still a positive takeaway. The tech giant is expected to continue its growth trajectory yet again, with earnings and revenue expected to be up 23% and 24%, respectively.
Image Source: Zacks Investment Research
As has been the case, cloud revenues will again be a key sentiment driver concerning the post-earnings reaction for the Mag 7 member. Google Cloud revenue totaled $20.0 billion in its latest release, reflecting a rock-solid 62.7% YoY growth rate. The growth acceleration is precisely what the market wanted to see, explaining the pop in shares following the latest release.
Further acceleration in the YoY growth rate will likely lead to huge positivity yet again from a share momentum standpoint, though it remains a tough hurdle to clear given the huge growth rates already delivered. Our consensus estimate for Google Cloud revenue stands at $22.8 billion, reflecting a 67% YoY change.
Image Source: Zacks Investment Research
Bottom Line
With the 2026 Q2 earnings season in full swing, investors will have a flurry of earnings reports to sort through in the coming weeks. The big banks kicked the period off in style, largely posting solid results while also providing solid read-throughs for coming periods.
And coming next week is a duo of Magnificent 7 members, namely Tesla (TSLA - Free Report) and Alphabet (GOOGL - Free Report) , who both head into their reports with favorable revisions for both earnings and revenue. Google Cloud results will remain key for Alphabet, whereas Tesla's AI-related CapEx and margin picture are key items to watch.
Boeing ponechal dvacetiletý výhled poptávky po letadlech beze změny a čeká 43 625 dodávek v letech 2026 až 2045. Firma zároveň odhaduje na počátku roku 2026 nedostatek téměř 2 000 letadel.
The Boeing logo on the doors to the Boeing factory in Renton, Washington, U.S., April 15, 2026. REUTERS/Genna Martin Purchase Licensing Rights, opens new tab
SummaryCompaniesBoeing forecast 43,625 deliveries from 2026 through 2045, including 33,545 single-aisle jetsBoeing estimates an undersupply of close to 2,000 aircraft entering 2026China is expected to account for 21% of deliveriesFARNBOROUGH, England, July 18 (Reuters) - Boeing (BA.N), opens new tab maintained its forecast for strong global demand for new commercial aircraft over the next 20 years, according to the U.S. planemaker's market projection released in England on Saturday, ahead of the Farnborough Airshow.
The U.S. planemaker's forecast was almost identical to its 2025 outlook. Boeing forecast industry-wide global deliveries of 43,625 new jetliners and freighters around the world from 2026 through 2045 -- 33,545 single-aisle jets, 7,715 widebody aircraft, 930 factory-built freighters and 1,435 regional jets.
The Reuters Iran Briefing newsletter keeps you informed with the latest developments and analysis of the Iran war. Sign up here.
This month, Boeing's European rival Airbus trimmed its projection by 1% to 42,060 new aircraft, citing the Iran war and trade tensions.
Boeing expects air passenger traffic growth of about 2.3% this year, less than half of last year's growth rate of 5.3%. It expects growth to rebound to 6%-7% in 2027 and 5%-6% in 2028.
"Our outlook is that passenger traffic globally will be where it would have been by the end of 2028," Boeing Commercial Marketing Vice President Darren Hulst told reporters. He described the current slowdown as different from the multi-year demand shock caused by the COVID-19 pandemic.
Boeing expects passenger traffic to grow 4% annually over the next 20 years, with cargo traffic rising 3.7%, the jet fleet expanding 3% and the world economy growing 2.5%.
Demand for new aircraft continues to grow faster than planemakers can deliver new jets. Passenger traffic last year had rebounded to pre-pandemic levels, but deliveries of new jets remained below the 2018 output, Hulst said.
The company estimates an undersupply of close to 2,000 aircraft entering 2026, with the single-aisle shortfall unlikely to clear until around the end of the decade and widebody shortages likely to persist into the early 2030s.
The outlook assumes a roughly even split between replacement and growth demand. Boeing projects 21,475 deliveries will replace older jets and 22,150 will support fleet expansion. The global fleet is expected to rise from about 28,000 aircraft in 2025 to 50,000 by 2045, with new-generation aircraft growing from 32% of the fleet to 92%.
China is expected to account for 21% of deliveries, followed by Eurasia at 20%, North America and South/Southeast Asia at 19% each, the Middle East and Africa at 10%, Latin America at 6% and Oceania/Northeast Asia at 5%.
Boeing's forecast reflects a market recovering from repeated shocks but still constrained by manufacturing capacity and supply-chain fragility. Boeing also faces certification delays on key programs including the 737 MAX 7 and 10 and the 777-9.
Hulst said the long-term demand picture remains supported by trade, tourism, migration and airline network expansion.
"The reason why we travel and the reason why goods move isn't changing," he said.
Reporting by Dan Catchpole in Seattle; Editing by David Gregorio
Our Standards: The Thomson Reuters Trust Principles., opens new tab
Duke Energy Carolinas se dohodla s regulátory v Severní Karolíně na snížení navrhovaného zvýšení sazeb o více než polovinu. Pokud bude schváleno Komisí pro veřejné služby v Severní Karolíně (NCUC), nové ceny začnou platit 1. ledna 2027.
Customer and stakeholder feedback informs more cost-effective way to reliably serve North Carolina's customers Duke Energy will contribute $10 million to help customers most in need , /PRNewswire/ -- After listening carefully to customer and stakeholder feedback, Duke Energy Carolinas and stakeholders have reached an agreement that will allow the company to continue building the infrastructure needed to reliably serve North Carolina while reducing the proposed rate increase by more than half.
The changes are reflected in a new agreement between the company and North Carolina Public Staff, the agency representing utility customers. Other parties to the agreement include Carolina Industrial Group for Fair Utility Rates, Carolina Utility Customers Association, North Carolina Sustainable Energy Association and Walmart, with others expected to join in the coming days.
Our view: "In light of the cost pressures our customers are facing, along with continued conversations with other stakeholders, we felt we had to do more," said Kendal Bowman, Duke Energy's North Carolina president. "We appreciate our stakeholders' engagement in finding a path that allows us to more cost-effectively serve the Tar Heel State. Our shareholders will also contribute $10 million to low-income bill assistance and weatherization programs – over and above our existing funding – which will make a real difference for customers who need help the most."
The company agreed to pursue similar terms for its Duke Energy Progress customers.
Agreement summary:
If approved by the North Carolina Utilities Commission (NCUC), the result is an average annual increase of 3.7% over two years. 9.8% return on equity and 53% equity component of the capital structure. New Multiyear Rate Plan (MYRP) refund rider will return money to customers, with interest, if planned infrastructure upgrades are not completed on time. Reduced customer costs for Belews Creek reliability upgrades due to federal funding. Why it matters: Since the request was initially filed last November, customers have made clear they're struggling to pay their bills, and Duke Energy has responded.
"We've agreed to reduce rates even more than in our prior settlements, while still allowing us to make vital infrastructure investments to meet existing and future customer needs," said Bowman. "Our duty is to protect reliability at the lowest possible cost, and we believe this agreement achieves that balance."
What's next: NCUC will consider the agreements and make the final decision – if approved, new rates will go into effect Jan. 1, 2027.
Duke Energy Carolinas serves about 2.3 million households and businesses in central and western North Carolina, including Charlotte, Durham and the Triad, while Duke Energy Progress serves about 1.6 million customers in central and eastern North Carolina and in the Asheville region.
Duke Energy Carolinas
Duke Energy Carolinas, a subsidiary of Duke Energy, owns 20,800 megawatts of energy capacity, supplying electricity to 3 million residential, commercial and industrial customers across a 24,000-square-mile service area in North Carolina and South Carolina.
Duke Energy
Duke Energy (NYSE: DUK), a Fortune 150 company headquartered in Charlotte, N.C., is one of America's largest energy holding companies. The company's electric utilities serve 8.7 million customers in North Carolina, South Carolina, Florida, Indiana, Ohio and Kentucky, and collectively own 55,700 megawatts of energy capacity. Its natural gas utilities serve 1.6 million customers in North Carolina, South Carolina, Ohio and Kentucky.
Duke Energy is executing an energy modernization strategy, keeping customer value at the forefront as it invests in electric grid upgrades and efficient generation resources to strengthen the system and serve growing energy needs.
More information is available at duke-energy.com. Follow Duke Energy on X, LinkedIn, Instagram, TikTok and Facebook for stories about the people and innovations powering its communities.
Abbott vyšetřuje dva kybernetické incidenty s neoprávněným přístupem do některých interních systémů v části onkologické diagnostiky a do portálu LabCentral. Firma uvedla, že její provoz nebyl zasažen a nečeká materiální dopad na byznys ani finanční výsledky.
A logo of Abbott at the company’s booth at the 8th China International Import Expo (CIIE) in Shanghai, China, November 6, 2025.REUTERS/Maxim Shemetov Purchase Licensing Rights, opens new tab
CompaniesJuly 17 (Reuters) - Abbott Laboratories (ABT.N), opens new tab is investigating two cyber incidents involving unauthorized access to some internal systems at its cancer diagnostics business and its LabCentral portal, the company said on Friday, adding that its operations were not affected.
No other businesses, sites or systems were impacted by the incident at the cancer diagnostics unit, the medical device maker said, adding that legacy Exact Sciences systems were separate from Abbott's systems.
The Reuters Daily Briefing newsletter provides all the news you need to start your day. Sign up here.
A hacker also allegedly gained access to the LabCentral portal, an externally facing third-party-hosted portal used by Abbott's core laboratory diagnostics business. But there had been no impact to its businesses or customers and no known exposure of sensitive customer or business information, the company said.
Cyberattacks have increasingly targeted healthcare companies, with recent incidents affecting firms such as Clover Health Investments (CLOV.O), opens new tab, Stryker (SYK.N), opens new tab, Medtronic (MDT.N), opens new tab, Novo Nordisk (NOVOb.CO), opens new tab and West Pharmaceutical Services (WST.N), opens new tab.
Such incidents can disrupt operations, impact access to data and add to concerns about safeguarding sensitive information.
LabCentral contained publicly available technical product reference documents, including operating manuals, troubleshooting checklists and product specifications, and did not contain proprietary or sensitive customer or business information, Abbott said.
The company added it had taken steps to address the matter, engaged outside cybersecurity experts and law enforcement, and was continuing to investigate what information may have been accessed.
Abbott does not expect any material impact on its business or financial results from the incidents.
Reporting by Padmanabhan Ananthan in Bengaluru; Editing by Jonathan Ananda
Our Standards: The Thomson Reuters Trust Principles., opens new tab
Bumble Inc. zakončila poslední obchodní seanci na 2,92 USD, což znamenalo denní pokles o 3,63 % a horší výkon než širší trh. Investoři čekají na výsledky, které firma oznámí 5. srpna 2026.
Bumble Inc. (BMBL - Free Report) ended the recent trading session at $2.92, demonstrating a -3.63% change from the preceding day's closing price. This change lagged the S&P 500's daily loss of 1.01%. Elsewhere, the Dow saw a downswing of 0.77%, while the tech-heavy Nasdaq depreciated by 1.4%.
Prior to today's trading, shares of the company had gained 2.36% outpaced the Computer and Technology sector's loss of 3.73% and the S&P 500's gain of 0.32%.
Market participants will be closely following the financial results of Bumble Inc. in its upcoming release. The company plans to announce its earnings on August 5, 2026. It is anticipated that the company will report an EPS of $0.25, marking a 60.94% fall compared to the same quarter of the previous year. At the same time, our most recent consensus estimate is projecting a revenue of $210.28 million, reflecting a 15.29% fall from the equivalent quarter last year.
In terms of the entire fiscal year, the Zacks Consensus Estimates predict earnings of $1.03 per share and a revenue of $834.42 million, indicating changes of +117.08% and -13.59%, respectively, from the former year.
Investors should also take note of any recent adjustments to analyst estimates for Bumble Inc. These revisions help to show the ever-changing nature of near-term business trends. Therefore, positive revisions in estimates convey analysts' confidence in the business performance and profit potential.
Our research demonstrates that these adjustments in estimates directly associate with imminent stock price performance. We developed the Zacks Rank to capitalize on this phenomenon. Our system takes these estimate changes into account and delivers a clear, actionable rating model.
The Zacks Rank system, which ranges from #1 (Strong Buy) to #5 (Strong Sell), has an impressive outside-audited track record of outperformance, with #1 stocks generating an average annual return of +25% since 1988. Over the past month, the Zacks Consensus EPS estimate has shifted 4.06% upward. Right now, Bumble Inc. possesses a Zacks Rank of #3 (Hold).
In terms of valuation, Bumble Inc. is currently trading at a Forward P/E ratio of 2.94. Its industry sports an average Forward P/E of 20.37, so one might conclude that Bumble Inc. is trading at a discount comparatively.
It's also important to note that BMBL currently trades at a PEG ratio of 0.1. This metric is used similarly to the famous P/E ratio, but the PEG ratio also takes into account the stock's expected earnings growth rate. As of the close of trade yesterday, the Internet - Software industry held an average PEG ratio of 1.11.
The Internet - Software industry is part of the Computer and Technology sector. This group has a Zacks Industry Rank of 86, putting it in the top 35% of all 250+ industries.
The Zacks Industry Rank is ordered from best to worst in terms of the average Zacks Rank of the individual companies within each of these sectors. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Keep in mind to rely on Zacks.com to watch all these stock-impacting metrics, and more, in the succeeding trading sessions.
Clover Health uvedla, že hacker pomocí sociálního inženýrství získal přístup ke třem účtům zaměstnanců a mohl vidět část osobních a chráněných zdravotních údajů. Firma nečeká materiální dopad na výsledky ani finanční situaci.
A man holds a laptop computer as cyber code is projected on him in this illustration picture taken on May 13, 2017. Capitalizing on spying tools believed to have been developed by the U.S.... Purchase Licensing Rights, opens new tab Read more
CompaniesJuly 17 (Reuters) - Clover Health Investments (CLOV.O), opens new tab said in a regulatory filing on Friday that it detected unusual login activity on some of its information systems on July 4 and later found a hacker had gained access to three employee accounts through social engineering.
Jumpstart your morning with the latest legal news delivered straight to your inbox from The Daily Docket newsletter. Sign up here.
The health insurer said the affected accounts belonged to non-managerial health plan employees who handled member visit scheduling and broker-facing sales work.
These accounts could access some personal and protected health information, according to the company, but not corporate financial or claims systems.
Clover began an investigation with external cybersecurity experts, took steps to contain the activity and notified law enforcement, it said.
The investigation is ongoing and the company is still reviewing what information may have been accessed or taken. Clover believes its response curbed and ended the unauthorized access.
It also said it does not believe the incident has had, or is likely to have, a material impact on its business, financial condition or results of operations.
Clover is reviewing legal and regulatory requirements and will notify affected members if needed, it added.
Clover Health Investments is a U.S. health insurer focused on providing Medicare Advantage plans and technology tools for doctors.
Reporting by Padmanabhan Ananthan in Bengaluru; Editing by Jonathan Ananda
Our Standards: The Thomson Reuters Trust Principles., opens new tab
HSK Chain integroval Euler Finance a spustil na síti neúschovní půjčování a vypůjčování krypta. Cílem je vyšší kapitálová efektivita pro uživatele i instituce.
HSK Chain, an Ethereum Layer-2 (L2) blockchain built by HashKey Group, is pleased to announce its strategic integration with Euler Finance, a decentralized lending protocol on the Ethereum blockchain. This partnership is aimed at enabling decentralized, non-custodial lending and borrowing on HSK Chain, along with improved on-chain capital efficiency for users and institutions.
🔔 Euler Finance @eulerfinance has officially deployed on HSK Chain.
As a modular DeFi lending protocol, Euler enables asset lending and borrowing on HSK Chain, helping global users and institutional investors improve capital efficiency.
1️⃣ Enables asset lending and borrowing… pic.twitter.com/MkVAKLiH9c
— HSK Chain (@HSKChain) July 17, 2026 HSK Chain is purposefully built to support decentralized applications (dApps) and Decentralized Finance (DeFi) services. It also provides infrastructure for scalable on-chain financial applications. Euler Finance permits users to lend and borrow crypto assets without depending on centralized parties. This integration is a combination of services from two blockchain-based platforms. HSK Chain has shared this news through its official social media X account.
Euler Finance Brings Flexible Crypto Lending and Borrowing to HSK Chain Euler Finance works in a non-custodial manner, which means users retain control of their assets throughout the lending process. Basically, Euler Finance is strategically deploying on HSK Chain, users will be able to lend and borrow digital assets on HSK Chain and also improve capital efficiency by allowing idle assets to earn yield.
Furthermore, Euler Finance expands DeFi opportunities for both retail users and institutional investors. No doubt, this collaboration empowers HSK Chain’s DeFi ecosystem by adding a trusted lending protocol. With this, users can attain more ways to utilize their assets while developers and institutions benefit from deeper liquidity and more efficient on-chain financial services.
Delivering Flexible On-Chain Lending Solutions The unification of HSK Chain and Euler Finance also facilitates a flexible non-custodial lending experience, giving users full control over their funds. Both platforms are entirely built on advanced technology and are successfully able to perform their duties around the world.
This integration is not confined only to developers, but it is also beneficial for institutions for deeper liquidity and more efficient on-chain financial services. This is a greatly admirable step from both partners toward users.
AUTHOR
Crypto journalist with years of experience providing in-depth analysis and news on blockchain and decentralized finance. With a keen eye for detail, Shahzaib delivers insightful articles that explore the latest trends, market movements, and innovations within the crypto and blockchain ecosystem. His work focuses on educating readers while offering expert commentary on the evolving landscape of digital assets, DeFi protocols, and the broader impact of blockchain technology.
Pentair tento týden klesl až o 18,5 % na nové 52týdenní minimum 57,60 USD poté, co snížil výhled tržeb za 2. čtvrtletí i za celý rok. K výprodeji přispěl i náhlý odchod CFO Nicholase Brazise.
If you want a masterclass in how to lose almost $2 billion in market value in a single week, just look at Pentair (PNR 4.93%). The stock slumped 18.5% at its lowest point in trading this week and hit a new 52-week low of $57.60 per share, according to data provided by S&P Global Market Intelligence.
What went wrong? Try a sudden C-suite exit, a brutal guidance cut, analyst downgrades, and a swarm of securities fraud investigations. It's a trainwreck.
Image source: Getty Images.
Everything that went wrong with Pentair It all started with a gut-punch of a preliminary earnings report. Pentair, which designs and manufactures water solutions from filtration and softening systems to swimming pool equipment, missed its own second-quarter revenue estimates. It expects Q2 sales to be down 17% against its previous guidance of 1% growth.
A pool inventory destocking is to blame. Basically, there's so much inventory out there that the distributors and retailers aren't buying more, hurting Pentair's pool segment's sales and income by $170 million and $105 million, respectively.
Pentair now sees full-year sales falling 4% to 7%. It earlier estimated sales to rise by 2% to 4% this fiscal year. With management also blaming inflation and high interest rates and explicitly stating that business conditions have worsened, the pain is unlikely to fade anytime soon.
Today's Change
(
-4.93
%) $
-3.24
Current Price
$
62.45
Then came the panic-inducing update of Pentair's Chief Financial Officer, Nicholas Brazis, abruptly quitting to join a private firm. Since he was named CFO just this March, the short stint and sudden exit spooked investors.
Analysts went into panic mode too, slashing their price targets for Pentair stock. Notable downgrades include Deane Dray from RBC Capital slashing the stock's price target from $101 per share to $74 apiece, and Nathan Jones from Stifel cutting the price objective to only $65 per share from $103 a share.
What's next for Pentair stock? Shareholder rights law firms immediately launched investigations into possible securities law violations, questioning internal controls surrounding Pentair's sales forecasts and disclosure of the true health of its sales channels, as well as the circumstances of the CFO's exit.
Where things stand now, it will be an uphill task for Pentair to regain investor confidence.
In the latest close session, Wix.com (WIX - Free Report) was down 2.54% at $51.45. The stock's change was less than the S&P 500's daily loss of 1.01%. Elsewhere, the Dow lost 0.77%, while the tech-heavy Nasdaq lost 1.4%.
The cloud-based web development company's shares have seen an increase of 24.24% over the last month, surpassing the Computer and Technology sector's loss of 3.73% and the S&P 500's gain of 0.32%.
Market participants will be closely following the financial results of Wix.com in its upcoming release. The company plans to announce its earnings on August 4, 2026. The company's earnings per share (EPS) are projected to be $1.19, reflecting a 47.81% decrease from the same quarter last year. Meanwhile, the Zacks Consensus Estimate for revenue is projecting net sales of $556.66 million, up 13.62% from the year-ago period.
Looking at the full year, the Zacks Consensus Estimates suggest analysts are expecting earnings of $4.57 per share and revenue of $2.26 billion. These totals would mark changes of -37.57% and +13.33%, respectively, from last year.
Investors should also note any recent changes to analyst estimates for Wixcom. These recent revisions tend to reflect the evolving nature of short-term business trends. Hence, positive alterations in estimates signify analyst optimism regarding the business and profitability.
Our research suggests that these changes in estimates have a direct relationship with upcoming stock price performance. To exploit this, we've formed the Zacks Rank, a quantitative model that includes these estimate changes and presents a viable rating system.
The Zacks Rank system, which ranges from #1 (Strong Buy) to #5 (Strong Sell), has an impressive outside-audited track record of outperformance, with #1 stocks generating an average annual return of +25% since 1988. Over the past month, the Zacks Consensus EPS estimate has shifted 58.73% downward. Wix.com is holding a Zacks Rank of #3 (Hold) right now.
Looking at its valuation, Wix.com is holding a Forward P/E ratio of 11.55. This indicates a discount in contrast to its industry's Forward P/E of 12.9.
It's also important to note that WIX currently trades at a PEG ratio of 0.73. The PEG ratio is akin to the commonly utilized P/E ratio, but this measure also incorporates the company's anticipated earnings growth rate. By the end of yesterday's trading, the Computers - IT Services industry had an average PEG ratio of 0.98.
The Computers - IT Services industry is part of the Computer and Technology sector. This group has a Zacks Industry Rank of 87, putting it in the top 36% of all 250+ industries.
The Zacks Industry Rank is ordered from best to worst in terms of the average Zacks Rank of the individual companies within each of these sectors. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Make sure to utilize Zacks.com to follow all of these stock-moving metrics, and more, in the coming trading sessions.
Akcie DocuSign v posledním obchodním dni klesly o 1,2 % na 52,74 USD, ale za poslední měsíc vzrostly o 22,8 %. Investoři čekají na výsledky hospodaření, kde analytici odhadují EPS 1,08 USD a tržby 868,04 milionu USD.
In the latest close session, DocuSign (DOCU - Free Report) was down 1.2% at $52.74. This change lagged the S&P 500's 1.01% loss on the day. Meanwhile, the Dow experienced a drop of 0.77%, and the technology-dominated Nasdaq saw a decrease of 1.4%.
The stock of provider of electronic signature technology has risen by 22.8% in the past month, leading the Computer and Technology sector's loss of 3.73% and the S&P 500's gain of 0.32%.
Investors will be eagerly watching for the performance of DocuSign in its upcoming earnings disclosure. In that report, analysts expect DocuSign to post earnings of $1.08 per share. This would mark year-over-year growth of 17.39%. Alongside, our most recent consensus estimate is anticipating revenue of $868.04 million, indicating a 8.42% upward movement from the same quarter last year.
Looking at the full year, the Zacks Consensus Estimates suggest analysts are expecting earnings of $4.54 per share and revenue of $3.49 billion. These totals would mark changes of +18.23% and +8.53%, respectively, from last year.
It is also important to note the recent changes to analyst estimates for DocuSign. These latest adjustments often mirror the shifting dynamics of short-term business patterns. Consequently, upward revisions in estimates express analysts' positivity towards the business operations and its ability to generate profits.
Based on our research, we believe these estimate revisions are directly related to near-term stock moves. To benefit from this, we have developed the Zacks Rank, a proprietary model which takes these estimate changes into account and provides an actionable rating system.
The Zacks Rank system, which varies between #1 (Strong Buy) and #5 (Strong Sell), carries an impressive track record of exceeding expectations, confirmed by external audits, with stocks at #1 delivering an average annual return of +25% since 1988. Over the past month, there's been a 1% rise in the Zacks Consensus EPS estimate. As of now, DocuSign holds a Zacks Rank of #3 (Hold).
Investors should also note DocuSign's current valuation metrics, including its Forward P/E ratio of 11.76. This denotes a discount relative to the industry average Forward P/E of 20.37.
We can additionally observe that DOCU currently boasts a PEG ratio of 0.7. Comparable to the widely accepted P/E ratio, the PEG ratio also accounts for the company's projected earnings growth. As of the close of trade yesterday, the Internet - Software industry held an average PEG ratio of 1.11.
The Internet - Software industry is part of the Computer and Technology sector. This group has a Zacks Industry Rank of 86, putting it in the top 35% of all 250+ industries.
The strength of our individual industry groups is measured by the Zacks Industry Rank, which is calculated based on the average Zacks Rank of the individual stocks within these groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
You can find more information on all of these metrics, and much more, on Zacks.com.
NetApp v poslední seanci vzrostl o 2,62 % na 163,88 USD, zatímco širší trh klesal. Trh čeká na výsledky, kde se počítá s EPS 2,11 USD a tržbami 1,83 miliardy USD.
In the latest trading session, NetApp (NTAP - Free Report) closed at $163.88, marking a +2.62% move from the previous day. The stock's change was more than the S&P 500's daily loss of 1.01%. At the same time, the Dow lost 0.77%, and the tech-heavy Nasdaq lost 1.4%.
The stock of data storage company has fallen by 0.01% in the past month, leading the Computer and Technology sector's loss of 3.73% and undershooting the S&P 500's gain of 0.32%.
The upcoming earnings release of NetApp will be of great interest to investors. The company's upcoming EPS is projected at $2.11, signifying a 36.13% increase compared to the same quarter of the previous year. At the same time, our most recent consensus estimate is projecting a revenue of $1.83 billion, reflecting a 17.43% rise from the equivalent quarter last year.
For the entire fiscal year, the Zacks Consensus Estimates are projecting earnings of $8.88 per share and a revenue of $7.48 billion, representing changes of +9.23% and +8.07%, respectively, from the prior year.
Any recent changes to analyst estimates for NetApp should also be noted by investors. These latest adjustments often mirror the shifting dynamics of short-term business patterns. As a result, upbeat changes in estimates indicate analysts' favorable outlook on the business health and profitability.
Our research shows that these estimate changes are directly correlated with near-term stock prices. To capitalize on this, we've crafted the Zacks Rank, a unique model that incorporates these estimate changes and offers a practical rating system.
The Zacks Rank system, running from #1 (Strong Buy) to #5 (Strong Sell), holds an admirable track record of superior performance, independently audited, with #1 stocks contributing an average annual return of +25% since 1988. Over the past month, the Zacks Consensus EPS estimate remained stagnant. Currently, NetApp is carrying a Zacks Rank of #3 (Hold).
In terms of valuation, NetApp is currently trading at a Forward P/E ratio of 17.99. This expresses a premium compared to the average Forward P/E of 14.84 of its industry.
One should further note that NTAP currently holds a PEG ratio of 2.35. Comparable to the widely accepted P/E ratio, the PEG ratio also accounts for the company's projected earnings growth. The Computer- Storage Devices was holding an average PEG ratio of 1.53 at yesterday's closing price.
The Computer- Storage Devices industry is part of the Computer and Technology sector. This group has a Zacks Industry Rank of 22, putting it in the top 9% of all 250+ industries.
The strength of our individual industry groups is measured by the Zacks Industry Rank, which is calculated based on the average Zacks Rank of the individual stocks within these groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
You can find more information on all of these metrics, and much more, on Zacks.com.
Fifth Third Bancorp (FITB) Q2 2026 Earnings Call July 17, 2026 9:00 AM EDT
Company Participants
Matt Curoe - Senior Director of Investor Relations
Timothy Spence - Chairman, CEO & President
Bryan Preston - Executive VP & CFO
Conference Call Participants
Ebrahim Poonawala - BofA Securities, Research Division
Manan Gosalia - Morgan Stanley, Research Division
Ryan Nash - Goldman Sachs Group, Inc., Research Division
L. Erika Penala - UBS Investment Bank, Research Division
Gerard Cassidy - RBC Capital Markets, Research Division
Michael Mayo - Wells Fargo Securities, LLC, Research Division
John Pancari - Evercore ISI Institutional Equities, Research Division
Brian Foran - Truist Securities, Inc., Research Division
Benjamin Gerlinger - Citigroup Inc., Research Division
Kenneth Usdin - Bernstein Autonomous LLP
Christopher McGratty - Keefe, Bruyette, & Woods, Inc., Research Division
Presentation
Operator
Hello, everyone. Thank you for joining us, and welcome to the Fifth Third's Second Quarter Earnings Call. [Operator Instructions]
I will now hand the conference over to Matt Curoe, Director of Investor Relations. Please go ahead.
Matt Curoe
Senior Director of Investor Relations
Good morning, everyone. Welcome to Fifth Third's Second Quarter 2026 Earnings Call. This morning, our Chairman, CEO and President, Tim Spence; and CFO, Bryan Preston, will provide an overview of our second quarter results and outlook.
Please review the cautionary statements in our materials, which can be found in our earnings release and presentation. These materials contain information regarding the use of non-GAAP measures and reconciliations to the GAAP results as well as forward-looking statements about Fifth Third's performance. These statements speak only as of July 17, 2026, and Fifth Third undertakes no obligation to update them. Following prepared remarks by Tim and Bryan, we will open up the call for questions.
With that, let me turn it over to Tim.
Timothy Spence
Chairman, CEO & President
Good morning, everyone, and thank you for joining us. At Fifth
Bank of England schválila HSBC Orion ke spuštění v rámci Digital Securities Sandbox. Platforma má podporovat vydávání, obsluhu a vypořádání digitálních cenných papírů včetně DIGIT.
HSBC wins Bank of England approval to enter Digital Securities SandboxThe Bank of England approved HSBC Orion to go live in its Digital Securities Sandbox, with the first Digital Gilt Instrument transaction expected in the first quarter of 2027.
HSBC, one of the world’s largest banks, has received approval to operate in the United Kingdom’s Digital Securities Sandbox (DSS), allowing its digital assets platform, HSBC Orion, to support the issuance, servicing and settlement of digital securities.
The bank announced Tuesday that HSBC Orion will operate as a digital securities depository within the DSS, a regulatory environment designed to test new technology for securities markets. HSBC said it is the first company approved by the Bank of England to go live in the sandbox.
HSBC’s platform will support digitally native bond issuance, including the UK’s planned digital sovereign bond — Digital Gilt Instrument (DIGIT) — and corporate bonds. HSBC said HSBC Orion has enabled more than $5 billion in digital bond issuances globally.
HM Treasury said Thursday that the first DIGIT transaction is expected by Q1 2027, adding that HSBC and London Stock Exchange Group also signed a memorandum of understanding to develop connectivity that supports investor access to the pilot issuance.
Launched in 2024, the DSS is operated by the Bank of England and the Financial Conduct Authority to test distributed ledger technology for issuing, trading and settling securities in a live regulatory environment.
Cointelegraph is committed to independent, transparent journalism. This news article is produced in accordance with Cointelegraph’s Editorial Policy and aims to provide accurate and timely information. Readers are encouraged to verify information independently.
, /PRNewswire/ -- The J.M. Smucker Co. (NYSE: SJM) today announced its Board of Directors approved an increase in the quarterly dividend from $1.10 to $1.12 per common share, an increase of two percent. The next dividend will be paid on Tuesday, September 1, 2026, to shareholders of record at the close of business on Friday, August 14, 2026. This increase marks the Company's 25th consecutive fiscal year of dividend growth, reflecting the Company's continued commitment to returning value to shareholders.
The J.M. Smucker Co. Forward-Looking Statement
This press release contains a forward-looking statement about dividends. This statement is made on the basis of the Company's views and assumptions as of this time, and the Company undertakes no obligation to update this statement unless required by law. This statement is not a guarantee of future performance, and actual events or results may differ materially from this statement. Investors should consult the Company's filings with the Securities and Exchange Commission (including the information set forth under the caption "Risk Factors" in the Company's Annual Report on Form 10-K for the fiscal year ended April 30, 2026) for information about certain factors that could cause such differences. Copies of these filings may be obtained by visiting the Company's website at jmsmucker.com.
About The J.M. Smucker Co.
At The J.M. Smucker Co., it is our privilege to make food people and pets love by offering a diverse family of brands available across North America. We are proud to lead in the coffee, peanut butter, fruit spreads, frozen handheld, sweet baked goods, dog snacks, and cat food categories by offering brands consumers trust for themselves and their families each day, including Folgers®, Dunkin'®, Café Bustelo®, Jif®, Uncrustables®, Smucker's®, Hostess®, Milk-Bone®, and Meow Mix®. Through our unwavering commitment to producing quality products, operating responsibly and ethically and delivering on our Purpose, we will continue to grow our business while making a positive impact on society. For more information, please visit jmsmucker.com.
The J.M. Smucker Co. is the owner of all trademarks referenced herein, except for Dunkin'®, which is a trademark of DD IP Holder LLC. The Dunkin'® brand is licensed to The J.M. Smucker Co. for packaged coffee products sold in retail channels, such as grocery stores, mass merchandisers, club stores, e-commerce and drug stores, and in certain away from home channels. This information does not pertain to products for sale in Dunkin'® restaurants.
BLB&G podala na AeroVironment hromadnou žalobu kvůli údajným nepravdivým tvrzením o kontraktu SCAR s americkým ministerstvem obrany. Firma později oznámila příkaz k zastavení prací, záměr smlouvu ukončit a odpis goodwillu ve výši 151,3 milionu USD.
NEW YORK--(BUSINESS WIRE)--Today, prominent investor rights law firm Bernstein Litowitz Berger & Grossmann LLP (“BLB&G”) filed a class action in the U.S. District Court for the District of Delaware alleging violations of the federal securities laws by AeroVironment, Inc. (“AeroVironment” or the “Company”) and certain of the Company’s current senior executives (collectively, “Defendants”). The action is brought on behalf of all investors who purchased or otherwise acquired AeroVironment common stock beginning at 4:30 PM ET on June 24, 2025, through June 18, 2026, inclusive (the “Class Period”). This case is related to a previously filed securities class action pending against AeroVironment captioned Norrell v. AeroVironment, Inc., No. 1:26-cv-1429 (E.D. Va. filed May 26, 2026) (“Norrell”).
BLB&G filed this action on behalf of its client, City Pension Fund for Firefighters and Police Officers in the City of Miami Beach, and the case is captioned City Pension Fund for Firefighters and Police Officers in the City of Miami Beach v. AeroVironment, Inc., No. 26-cv-00875 (D. Del.). The complaint is based on an extensive investigation and a careful evaluation of the merits of this case. A copy of the complaint is available on BLB&G’s website by clicking here.
AeroVironment’s Alleged Fraud
AeroVironment is a defense technology provider across air, land, sea, space, and cyber. Shortly before the Class Period, AeroVironment acquired BlueHalo, LLC (“BlueHalo”), another defense technology company with a leading role in the U.S. Department of Defense’s (“DoD”) Satellite Communications Augmentation Resource (“SCAR”) program. Through SCAR, BlueHalo had been awarded a contract valued at approximately $1.7 billion to develop military satellite command and control stations known as Broad Area Deployable Ground Terminal Enabling Resilient Communications (“BADGERs”).
The claims against AeroVironment and certain of its executives arise from misrepresentations relating to the SCAR contract. Throughout the Class Period, Defendants repeatedly touted the SCAR program as central to AeroVironment’s growth prospects. Defendants told investors that the Company had “won” the SCAR contract, that it was “locked in,” that the customer was “asking for more,” and that the Company was “very much on track” to ramp revenue and improve margins as more BADGER systems moved into production. In truth, AeroVironment’s agreement with the U.S. DoD to produce BADGERs for the SCAR program was not secure, as AeroVironment was facing a significant threat of competition from other vendors for the work it was performing under that agreement, and there was a material risk that the Company would not continue to deliver products for the SCAR program, or would do so only on a significantly reduced basis.
The truth began to emerge on January 20, 2026, when AeroVironment announced that the U.S. Government had issued a stop work order on the SCAR contract. As a result of this disclosure, the price of AeroVironment common stock declined by $61.97 per share, or 16%. Then, on March 2, 2026, industry publication Space News reported that the U.S. DoD was reopening the SCAR program and soliciting proposals from vendors other than AeroVironment because the Space Force was “reassessing how to move forward.” That news caused the price of AeroVironment common stock to decline by $43.93 per share, or 17%.
On March 10, 2026, AeroVironment revealed that the U.S. Government intended to terminate the SCAR agreement, while allowing AeroVironment to compete for future work under the program. The Company also reported a $151.3 million goodwill impairment charge in the Space reporting unit triggered by the SCAR stop work order. These disclosures caused the price of AeroVironment common stock to decline by $13.84 per share, or 6%. Then, on June 22, 2026, AeroVironment disclosed that its previously issued financial statements should no longer be relied upon because the Company had understated the goodwill impairment charge by $89.4 million, or 59%. AeroVironment further disclosed that the restatement resulted from a newly identified material weakness in internal control over financial reporting and that its disclosure controls and procedures as of January 31, 2026, were ineffective. As a result of these disclosures, the price of AeroVironment common stock declined by $18.28 per share, or 11%.
The filing of this action does not alter the previously established deadline to seek appointment as Lead Plaintiff. Pursuant to the May 27, 2026, notice published in connection with the Norrell action, under the Private Securities Litigation Reform Act of 1995, investors who purchased AeroVironment common stock during the Class Period may, no later than July 27, 2026, seek to be appointed as Lead Plaintiff for the Class. Any member of the proposed Class may seek to serve as Lead Plaintiff through counsel of their choice, or may choose to do nothing and remain a member of the proposed Class.
If you wish to discuss this action or have any questions concerning this notice or your rights or interests, please contact Scott R. Foglietta of BLB&G at 212-554-1903, or via e-mail at [email protected].
About BLB&G
BLB&G is widely recognized worldwide as a leading law firm advising institutional investors on issues related to corporate governance, shareholder rights, and securities litigation. Since its founding in 1983, BLB&G has built an international reputation for excellence and integrity and pioneered the use of the litigation process to achieve precedent-setting governance reforms. Unique among its peers, BLB&G has obtained several of the largest and most significant securities recoveries in history, recovering over $40 billion on behalf of defrauded investors. More information about the firm can be found online at www.blbglaw.com.
Zentalis Pharmaceuticals oznámila, že na kongresu ESMO 2026 v Madridu představí rychlou ústní prezentaci s daty o celkovém přežití ze studie DENALI Part 1b s azenosertibem, a to v pátek 23. října 2026.
July 17, 2026 16:15 ET | Source: ZENTALIS PHARMACEUTICALS
Rapid oral presentation to highlight overall survival data from the DENALI Part 1b study of azenosertib
SAN DIEGO, July 17, 2026 (GLOBE NEWSWIRE) -- Zentalis® Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical oncology innovator advancing late-stage development of investigational first-in-class WEE1 inhibitor azenosertib as a biomarker-driven treatment approach for ovarian cancer, today announced two presentations at the European Society for Medical Oncology (ESMO) Congress 2026, taking place October 23-27, 2026, in Madrid, Spain.
"We are pleased that the overall survival results from the DENALI Part 1b study are accepted as a rapid oral presentation at ESMO.” said Julie Eastland, Chief Executive Officer. “The data will showcase the long-term survival benefits demonstrated by azenosertib in patients with Cyclin E1-positive platinum-resistant ovarian cancer in this study and further support our strategic focus on advancing azenosertib in registration-intended monotherapy trials for this biomarker-selected patient population with high unmet need.”
Rapid oral presentation:
Title: “Azenosertib in platinum-resistant ovarian cancer (PROC): overall survival analysis from Part 1b of the DENALI study (GOG-3066)”
Date/Time: Friday, October 23, 2026, 4:15 p.m. - 5:45 p.m. CEST
Presentation Number: 1242RO
Trial-in-progress poster presentation:
Title: “ASPENOVA: A phase 3 study of azenosertib monotherapy versus standard of care chemotherapy in cyclin E1-positive platinum-resistant ovarian cancer (PROC)”
Date/Time: Monday, October 26, 2026, 12:00 p.m. - 12:45 p.m. CEST
Presentation Number: 1339TiP
About DENALI Clinical Trial
DENALI is a multi-part Phase 2 registration-intended clinical trial (NCT05128825) studying azenosertib in PROC patients.
Part 1b enrolled patients with PROC regardless of Cyclin E1 protein expression, all treated at 400mg QD 5:2 (5 days once-daily administration of azenosertib, followed by 2 days without azenosertib).
Part 2 is prospectively enrolling PROC patients with Cyclin E1 protein overexpression based on Zentalis' proprietary immunohistochemistry cutoff. Part 2, in total, is designed to support accelerated approval, pending positive study outcomes and further discussions with the FDA. The study design consists of the following parts:
Part 2a: Dose confirmation evaluated two doses, 300mg QD 5:2 and 400mg QD 5:2, with approximately 30 patients enrolled per dose group. 400mg QD 5:2 was selected as the optimal monotherapy dose. Recruitment at the 300mg QD 5:2 dose level has been discontinued. All patients enrolled in Part 2a will contribute to the overall safety database submitted to the FDA.Part 2b: Enrollment expansion at the selected 400mg QD 5:2 dose up to approximately 100 patients, including patients at this dose in Part 2a. This cohort is currently enrolling.Part 2c: Broadening study population, which is expected to include approximately 40 patients previously treated with a taxane-containing regimen for PROC. This cohort is currently enrolling. For physician and patient information about the DENALI trial, please visit www.denalitrial.com.
About ASPENOVA Clinical Trial
ASPENOVA is a Phase 3 randomized, confirmatory clinical trial designed to support full approval of azenosertib in patients with Cyclin E1-positive PROC. The trial is expected to enroll approximately 420 patients and compare azenosertib monotherapy at 400mg QD 5:2 to investigator's choice of standard-of-care single-agent chemotherapy (paclitaxel, pegylated liposomal doxorubicin [PLD], gemcitabine, or topotecan) in this biomarker-selected population. The primary endpoint is progression-free survival (PFS); key secondary endpoints include overall survival (OS) and overall response rate (ORR). The trial design was based on feedback from the U.S. FDA regarding requirements for seeking approval under the accelerated approval pathway and requirements to support potential conversion to full approval.
About Azenosertib
Azenosertib is an investigational, potentially first-in-class, selective, and orally bioavailable inhibitor of WEE1 currently being evaluated in clinical studies in ovarian cancer and additional tumor types. WEE1 acts as a master regulator of the G1-S and G2-M cell cycle checkpoints, through negative regulation of both CDK1 and CDK2, to prevent replication of cells with damaged DNA. By inhibiting WEE1, azenosertib enables cell cycle progression, despite high levels of DNA damage, thereby resulting in the accumulation of DNA damage and leading to mitotic catastrophe and cancer cell death.
Azenosertib is in late-stage development as a potential treatment for Cyclin E1-positive platinum-resistant ovarian cancer (PROC). There is currently no approved treatment option specifically for this biomarker-selected population which comprises approximately 50% of PROC patients. Cyclin E1 protein overexpression has been established as a sensitive and specific predictive biomarker for identifying patients who could potentially derive benefit from azenosertib treatment.
About Zentalis Pharmaceuticals
Zentalis is a clinical oncology innovator developing a treatment approach for ovarian cancer and multiple tumor types. Leveraging therapeutics development and biomarker expertise, Zentalis is advancing monotherapy and combination studies of its investigational first-in-class WEE1 inhibitor, azenosertib. Focused on translating WEE1 science into clinical practice, we aim to equip physicians with a targeted, non-chemo, orally available medicine that enhances treatment experience, choice, and outcomes. Our mission: to unburden cancer patients with more convenience and care.
For more information, please visit www.zentalis.com. Follow Zentalis on LinkedIn at www.linkedin.com/company/zentalis-pharmaceuticals
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995, as amended. All statements contained in this press release that do not relate to matters of historical fact should be considered forward-looking statements, including, but not limited to, statements regarding the continued development of azenosertib; the clinical and therapeutic potential of azenosertib; the potential for azenosertib to be first-in-class;; the broad franchise potential of azenosertib; the Company’s biomarker-driven strategy for azenosertib; and our participation in poster presentations. The terms “anticipate,” “advance,” “believe,” “design,” “develop,” “expect,” “intent,” “look forward,” “on track,” “plan,” “position,” “potential,” “runway,” “strategy,” “support,” “target,” “upcoming,” and “will” and similar references are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. These statements are neither promises nor guarantees, but involve known and unknown risks, uncertainties and other important factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements, including, but not limited to, the following: our limited operating history, which may make it difficult to evaluate our current business and predict our future success and viability; we have and expect to continue to incur significant losses; our need for additional funding, which may not be available; our substantial dependence on the success of azenosertib; our plans, including the costs thereof, of development of companion diagnostics; the outcome of preclinical testing and early trials may not be predictive of the success of later clinical trials; potential unforeseen events during clinical trials could cause delays or other adverse consequences; risks relating to the regulatory approval process or ongoing regulatory obligations; our product candidates may cause serious adverse side effects; inability to maintain our collaborations, or the failure of these collaborations; our reliance on third parties; effects of significant competition; the possibility of system failures or security breaches; risks relating to intellectual property; our ability to attract, retain and motivate qualified personnel, and risks relating to management transitions; significant costs as a result of operating as a public company; and the other important factors discussed under the caption “Risk Factors” in our most recently filed periodic report on Form 10-K or 10-Q and subsequent filings with the U.S. Securities and Exchange Commission (SEC) and our other filings with the SEC. Any such forward-looking statements represent management’s estimates as of the date of this press release. While we may elect to update such forward-looking statements at some point in the future, we disclaim any obligation to do so, even if subsequent events cause our views to change.
ZENTALIS® and its associated logo are trademarks of Zentalis and/or its affiliates. All website addresses and other links in this press release are for information only and are not intended to be an active link or to incorporate any website or other information into this press release.
PriceSmart rozšiřuje síť skladových klubů v Latinské Americe a Karibiku; k 31. května 2026 měl 57 klubů. Míra obnovení členství dosáhla ve 3. čtvrtletí 2026 90,5 %.
The aisles are packed with the same bulk goods you would find in a California suburb: 50-pound bags of rice, high-end electronics, and automotive supplies. But this isn't California. It's a shopping hub in the Caribbean, and the customers waiting in line are members of PriceSmart (PSMT 1.61%), a company that has exported the U.S. warehouse club model to the emerging markets of Latin America and the Caribbean. Trading at $194.56 as of July 14, 2026, the stock has rallied over 80% over the past year, reflecting investor appetite for its consistent, consumption-based business model despite regional headwinds.
Our proprietary Hidden Gems scoring system assigns PriceSmart an overall Superscore of 79 out of 100, placing it in the Strong category. The Superscore is an AI-powered score that evaluates a company's overall strength by combining financial performance, product market position, technological capabilities, leadership quality, and relative valuation. It represents the unification of all our scores into a single score for public companies, with five rating bands: Exceptional (90-100), Strong (75-89), Above Average (60-74), Average (40-59), and Cautious (0-39).
Image source: Getty Images.
Why PSMT Has a 79 SuperscoreDisciplined expansion: Management has successfully scaled the footprint to 57 clubs as of May 31, 2026, with an active pipeline of new locations in Chile, Costa Rica, and the Caribbean, driving reliable growth in its store count.Pricing power: The company had successfully implemented a $5 membership fee increase in fiscal 2024 without triggering significant churn, confirming that the membership value proposition remains sticky.Recurring revenue: Membership renewal rates have shot up to 90.5% as of the third quarter of 2026, providing a predictable, high-margin revenue base that serves as a critical buffer against the inherent volatility of the retail sector.Operational modernization: Investments in the RELEX supply chain platform and the Elera point-of-sale system are actively removing operational friction, allowing for better inventory management and deeper digital member engagement.Why Is PSMT's Superscore Not Higher?Currency volatility: Operations span diverse economies across Latin America and the Caribbean, meaning foreign exchange shifts often pressure reported margins, even when underlying constant-currency performance remains robust.Valuation premium: The stock trades at a trailing P/E of 37.34, a high multiple that implies significant future growth expectations, potentially leaving little margin for error if expansion velocity slips.Regional dependence: The company is inherently tied to the economic health and political stability of its operating regions, introducing a structural risk profile that is more complex than that of domestic retail peers.Hidden Gems Database Scores at a GlanceScoreScore (out of 100)Supporting Data PointProduct (1Y)83Operational momentum is driven by a 13.7% increase in membership income and the successful rollout of advanced technology stacks like RELEX.Product (5Y)74The company maintained a 9.8% revenue CAGR from 2021 to 2025, demonstrating steady execution in a niche regional market.Financial (1Y)73Fiscal 2025 results featured a 25.9% surge in operating cash flow to $261.3 million, highlighting improved conversion efficiency.Financial (5Y)74Consistent profitability has been underpinned by stable net margins of 2.7% and a low debt-to-equity ratio of 0.26 as of fiscal 2025.Leaders95Management maintains a transparent, long-term capital allocation strategy with a 99.3% shareholder approval rating on compensation policies.AI17The business operates as a traditional retailer without the proprietary datasets required for advanced data-driven competitive advantages.Valuation Risk53The stock carries a trailing P/E of 37.34, which suggests the market has already priced in substantial future growth.Who Should Buy PSMT Stock Now?You should consider investing if...
You are seeking long-term exposure to emerging market growth through established consumer staples stocks that benefit from a sticky, membership-based recurring revenue model.You are comfortable with geographic diversification outside of the U.S. and believe the warehouse club format will continue to gain traction among growing middle-class families in Latin America.You may want to avoid this stock if...
You have a low tolerance for the currency fluctuations and macroeconomic instability that often impact retailers operating in developing regional markets.You prioritize bargain-priced stocks, as the current valuation appears to fully account for the company's expansion roadmap and leaves little room for operational disappointments.The Superscore serves as a data-driven foundation for research, but investors should always weigh this framework against their personal risk tolerance and financial goals before making an investment decision.
Today's Change
(
-1.61
%) $
-3.05
Current Price
$
186.00
My 5-year prediction for PSMT stockPriceSmart’s growth strategy is centered around expanding its warehouse club network across Latin American and the Caribbean. It’s a membership-based retail outlet that benefits from increasing demand among consumers to shop at lower-cost stores.
In addition, PriceSmart has a large number of loyal customers who continue to purchase items at their stores due to lower prices and superior services. In the third quarter, net merchandise sales grew 12.5%, with comparable sales growing 10.7% year over year. Importantly, membership grew at a solid clip of 8.6% to 2.1 million, while renewal rates hit an all-time high of 90.5%. Membership income grew 17.6%, thanks to management rolling out an auto-renewal strategy.
PriceSmart is developing its regional footprint, with Chile set to open its first club in a Santiago mall. Management is investing $100 million for three clubs and supporting offices over the next few years.
Over the next five years, I wouldn’t be surprised if sales continue to grow in the low- to mid-double-digit range. However, management also acknowledged near-term headwinds as selling, general, and administrative (SG&A) costs spike when new clubs come online. Additionally, uncertain trade policies could also weigh on growth.
Overall, PriceSmart remains a solid long-term investment, with momentum firmly on the business’s side.
The Hidden Gems Superscore reflects The Motley Fool's proprietary AI-driven evaluation of a company across product, financial, leadership, and valuation pillars as of the article date and may change over time. Performance figures are point-in-time. Past performance does not guarantee future results.
Akcie Sweetgreen v pátek vyskočily o 15 %, když regulátoři spojili propuknutí cyklosporiázy s Taco Bell, nikoli s řetězcem salátů. Intradenně přidaly až 21 %.
Sweetgreen stock jumped 15% Friday, paring back a massive four-day slump, after regulators traced an explosive diarrhea outbreak back to Taco Bell restaurants – sparing the salad bowl chain’s reputation.
The fast-casual salad chain – known for its so-called “slop bowls” – saw its stock soar as much as 21% Friday for its biggest intraday gain since August 2024.
It plummeted nearly 26% from Monday through Thursday’s close as investors feared consumers would steer clear of fresh produce as thousands of people across several US states were sickened by cyclosporiasis.
Sweetgreen – known for its so-called “slop bowls” – saw its stock soar as much as 21% Friday. Boston Globe via Getty Images The Centers for Disease Control and Prevention and the Food and Drug Administration said late Thursday that they had linked the outbreak to shredded iceberg lettuce served at a handful of Taco Bell restaurants in Indiana, Kentucky, Michigan, Ohio and West Virginia.
On Friday, Bloomberg reported that Taylor Farms, a California-based fresh produce supplier, is preparing to recall ingredients linked to the outbreak.
“Sweetgreen does not use iceberg lettuce in our menu,” a spokesperson for Sweetgreen said in a statement.
“From the outset of the investigation, we have been in close contact with our suppliers to determine whether any ingredients in our supply chain have been identified as part of the investigation. To date, none have been.”
Shares of Sweetgreen are still down nearly 15% this week, while Taco Bell has fallen about roughly 8% during the same timeframe – similarly regaining some losses after the fast-food giant said it has removed lettuce from the tainted supplier nationwide.
The FDA said it was able to link the outbreak to the burrito-and-taco chain after more than 1,644 sick people suffering from cyclosporiasis reported eating at Taco Bell locations in five states.
Shares of Sweetgreen are still down nearly 15% this week. Ai – stock.adobe.com Regulators said they are working directly with the unnamed supplier – now reportedly believed to be Taylor Farms – to determine if the contaminated iceberg lettuce was sent to any other partners.
Cyclospora is a microscopic parasite that is typically transmitted when infected feces contaminates food or water, according to the FDA.
It can cause an intestinal illness called cyclosporiasis, characterized by symptoms like watery diarrhea, loss of appetite, weight loss, stomach cramps or pain, bloating, gas, nausea and fatigue, according to food safety regulators. Some people may become infected and be asymptomatic.
The main risk from cyclosporiasis is dehydration that can lead to more serious complications. Those most at risk include people with weakened immune systems, the elderly and children.
D-Wave Quantum (QBTS) v červenci klesl o 29,4 % kvůli výběru zisků, obavám z ocenění a makroekonomickým faktorům. Firma čeká na výsledky za 2. čtvrtletí a plánuje přesun kotace z NYSE na Nasdaq.
Key Takeaways D-Wave Quantum has fallen 29.4% in July amid profit-taking, valuation concerns and macro headwinds.QBTS plans a Nasdaq listing transfer and expanded quantum research with an NSF-backed subsidiary grant.QBTS faces weak technical signals as investors await second-quarter earnings and further execution updates. The sharp pullback in D-Wave Quantum (QBTS - Free Report) this month has shifted investor attention from the quantum computing sector's long-term promise to its near-term execution risks. After delivering substantial gains earlier this year, the stock has fallen 29.4% month to date, underperforming the Computer and Technology sector's 1.4% decline and the S&P 500's 1.2% gain.
The weakness reflects a combination of profit-taking after the stock's outsized gains earlier this year, valuation concerns across high-growth quantum names and a macroeconomic backdrop marked by elevated U.S. Treasury yields and expectations that the Federal Reserve will keep interest rates higher for longer. These conditions have weighed disproportionately on speculative technology stocks despite continued enthusiasm for artificial intelligence and quantum computing.
During the same period, QBTS' pure-play quantum computing peers, IonQ (IONQ - Free Report) and Rigetti Computing (RGTI - Free Report) , also witnessed sharp share price declines of 34.1% and 27%, respectively.
Month-to-Date Share Price Comparison
Image Source: Zacks Investment Research
Will July Catalysts Change QBTS' Trajectory?D-Wave Quantum will report its second-quarter earnings in early August. While the stock has remained under pressure amid a broader selloff of speculative growth companies, the company's strategic execution continues to advance. Most notably, D-Wave announced plans to transfer its listing from the NYSE to the Nasdaq later this month, a move expected to enhance its visibility among technology-focused investors and potentially broaden its shareholder base. The company also disclosed that its Quantum Circuits subsidiary received a U.S. National Science Foundation grant to support research in fault-tolerant quantum computing, further strengthening D-Wave's expansion beyond quantum annealing into gate-model quantum systems.
The broader industry backdrop also remains constructive. NVIDIA (NVDA - Free Report) recently introduced an open-source AI decoder that significantly improves quantum error-correction performance, while IBM reaffirmed plans to invest more than $10 billion in quantum technologies over the coming years. Meanwhile, governments across the United States and Europe continue to expand funding for quantum research and commercialization. These developments strengthen the long-term growth opportunity for the sector, although they are yet to offset near-term concerns surrounding elevated valuations, higher Treasury yields and a "higher-for-longer" interest-rate environment that continues to put pressure on pre-profit technology companies.
What Do the Estimates Say?The earnings estimate chart indicates that D-Wave is expected to report a second-quarter loss of 8 cents per share, representing an 85.5% improvement from the year-ago quarter. For full-year 2026, the consensus estimate calls for a loss of 25 cents per share, reflecting a 77.5% improvement from 2025. Despite the broader market selloff, the absence of estimate revisions suggests that analysts have adopted a wait-and-see stance ahead of the company's second-quarter earnings release.
Image Source: Zacks Investment Research
Technical Pressure RemainsThe technical picture remains weak. As the chart shows, QBTS is trading well below both its 50-day SMA and 200-day SMA, indicating sustained bearish momentum. While the sharp correction reflects deteriorating near-term sentiment, upcoming catalysts, including the Nasdaq listing transition and second-quarter earnings, could determine whether the stock stabilizes or extends its decline.
QBTS 50-&-200-Day SMAs
Image Source: Zacks Investment Research
Our TakeDespite near-term macro headwinds and a weak technical setup, D-Wave's strengthening fundamentals and strategic execution support a constructive long-term outlook. The planned Nasdaq listing, continued expansion into gate-model quantum computing and strong earnings expectations position the company favorably ahead of its second-quarter results. Consistent with its Zacks Rank #2 (Buy), we believe the recent pullback offers a buying opportunity for investors willing to look beyond near-term volatility, while recognizing that technical weakness may persist until fresh business catalysts emerge. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Tesla přidala Miami jako pátý robotaxi trh a v Texasu má už 175 vozidel, tedy o více než 100 vozidel více za poslední měsíc. Bank of America ponechala hodnocení Buy a cílovou cenu 460 USD.
The firm notes that Tesla has added Miami as its fifth robotaxi market and is scaling its Texas fleet at the fastest pace among operators it tracks. The combination matters because it shifts Tesla’s story from promise to visible expansion, even if the network is still early and uneven.
TSLA stock is moving. See the chart and price action here. Tesla Adds Robotaxi Markets and VehiclesTesla’s Texas fleet now stands at 175 vehicles, up by more than 100 in the past month, according to the note. That kind of growth gives Tesla a stronger case that its robotaxi effort is more than a demo. It is building an actual operating footprint.
Bank of America also points out that Tesla now has four additional markets in preparation, which suggests the company is still pushing toward the original goal of nine cities by the first half of 2026. Miami’s launch adds another proof point that Tesla wants to expand quickly while interest in autonomous driving remains high.
The robotaxi push is only one part of the bull case. Tesla’s second-quarter deliveries came in around 480,000, far above Street expectation. BofA also says the company likely gained global battery-electric vehicle share which helps offset worries that the core auto business is slowing.
The TakeawayBank of America kept its Buy rating and $460 price target on TSLA. The firm views Tesla as trying to turn autonomy into a real business while the EV business still supports the base case.
For now, the most important question is whether the company can keep adding markets, vehicles and usage fast enough to justify its robotaxi ambition.
TSLA Stock Price Activity: Tesla stock was down 2.32% at $381.98 at the time of publication Friday, according to data from Benzinga Pro.
Over the past month, TSLA has declined about 5.0% versus a 0.9% decline in the S&P 500 and is down roughly 17% year-to-date compared to the index’s 8.5% gain.
Photo: Shutterstock
This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.
Market News and Data brought to you by Benzinga APIs
Akcie Microsoftu v pátek klesly o 1,5 % a několik analytiků před výsledky za 4. fiskální čtvrtletí snížilo cílové ceny. Citi je stáhla na 570 USD z 620 USD a ponechala doporučení Buy.
Microsoft NASDAQ:MSFT shares fell 1.5% on Friday, extending a difficult year for the software giant as investors continued to weigh heavy artificial intelligence spending against the company's long-term growth prospects.
The stock has declined more than 20% in 2026 and nearly 23% over the past year, even as Microsoft has continued investing aggressively in AI infrastructure and Azure cloud services.
Several Wall Street firms revised their price targets this week ahead of Microsoft's fiscal fourth-quarter earnings report on July 29, while largely maintaining bullish ratings on the stock.
Wall Street lowers targets but maintains bullish ratingsCiti reduced its price target on Microsoft to $570 from $620 while maintaining a Buy rating.
According to reports, the firm said the lower target reflected broader valuation compression across software stocks rather than any deterioration in Microsoft's business fundamentals.
The bank said its channel checks remained positive, highlighting healthy adoption of Microsoft 365 Copilot and the company's positioning as enterprises increasingly optimize AI spending.
Citi expects Microsoft to deliver a strong fiscal fourth-quarter report but believes investors will focus closely on management's outlook for fiscal 2027, particularly regarding operating margins and capital expenditure.
Other brokerages also adjusted their targets.
Mizuho analyst Gregg Moskowitz lowered his price target to $490 from $515 while maintaining an Outperform rating.
"SaaS (software-as-a-service) continues to be resilient, although multiples continue to be plagued by investor concerns about AI-led disruption," Moskowitz said in a research report on software stocks.
He added that Microsoft continues to see improvement in its Azure cloud computing and Microsoft 365 Copilot businesses despite broader concerns surrounding AI-native competitors and infrastructure spending.
Wells Fargo also lowered its price target to $625 from $650 while maintaining its Overweight rating, citing questions around cloud market share and the pace of capital expenditure.
Evercore ISI moved in the opposite direction, raising its price target to $525 from $510 while maintaining an Outperform rating.
Microsoft is scheduled to report fiscal fourth-quarter results after the market closes on July 29.
Consensus estimates compiled by Fiscal AI and Koyfin call for earnings of $4.24 per share on revenue of $86.66 billion.
Analysts expect Azure growth and operating margin guidance to be the primary focus during the earnings release.
While Citi expects the fourth-quarter results to be solid, the firm believes management's commentary on fiscal 2027 could prove more important for investors as Microsoft continues expanding its AI infrastructure.
Heavy AI investments remain under scrutinyMicrosoft's aggressive capital spending remains one of the biggest concerns for investors.
The company spent $30.88 billion on capital expenditures during its fiscal third quarter, up 84.4% from a year earlier.
According to Forbes estimates, Microsoft's total fiscal 2026 capital expenditure could reach approximately $190 billion as the company continues investing in AI data centers, Azure infrastructure and computing capacity.
The elevated spending has pressured margins and free cash flow, contributing to the stock's underperformance despite continued business growth.
At the same time, analysts note that enterprise demand for AI remains healthy.
Bernstein's mid-year CIO survey pointed to strong IT budget growth in 2026, supporting Azure demand, although investors continue to monitor whether Microsoft can translate that investment into market share gains and stronger financial returns.
Nvidia's (NVDA 1.97%) next-generation Vera Rubin processors and chip systems will be one of the most important product releases in the company's history, so a report about a potential delay in the rollout of the chip giant's upcoming platform is something that investors won't want to see right now.
KeyBanc Capital Markets analyst John Vinh and research firm SemiAnalysis recently noted that thermal issues, problems with the qualification of high-bandwidth memory (HBM), and manufacturing problems with networking components could delay the launch of the Rubin systems. However, Nvidia CEO Jensen Huang quickly quashed such reports, noting that the company is on track to deliver huge volumes of Vera Rubin systems this year.
Here's what he said.
Image source: Nvidia Corporation.
Nvidia is on track to produce Vera Rubin systems in "giant" volumes Bloomberg points out that the reports of a delay in Vera Rubin's rollout are "not true," according to Huang. The Nvidia CEO further said -- "Vera Rubin is already in production. Giant amounts of production incoming."
These comments indicate that Nvidia is on track to meet the incredible demand for its Vera Rubin systems. A potential delay could have slowed down the company's incredible growth trajectory, which is set to improve due to the Rubin systems. After all, the company is anticipating a gigantic $1 trillion in revenue from sales of Vera Rubin and Blackwell processors in 2026 and 2027.
Today's Change
(
-1.97
%) $
-4.09
Current Price
$
203.31
That's double the $500 billion revenue the company was anticipating from these two chip architectures in 2025 and 2026. Clearly, Nvidia sees Vera Rubin as a key driver of its top line for the next couple of years, and Huang's comments suggest that it is indeed on track to deliver an uptick in growth. One of the most important reasons why Vera Rubin will supercharge Nvidia's growth is that it can significantly reduce artificial intelligence (AI) inference costs.
Moreover, Nvidia dominates the AI inference market despite rising competition, and Vera Rubin should ideally help it cement its leadership. As such, it is easy to see why analysts are bullish about Nvidia and expect this AI stock to deliver impressive gains over the coming year.
Wall Street expects Nvidia stock to jump higher, but it could do better Nvidia's 12-month median price target of $300 points to a potential jump of 45%. What's more, 62 of the 66 analysts covering Nvidia stock rate it as a buy. However, Nvidia could soar past the median price target.
Nvidia's earnings-per-share growth is poised to accelerate in fiscal 2027 to 88%, well above last year's 60% growth. The forecast for the next couple of years points toward a sustained improvement in its bottom line.
Data by YCharts
If Nvidia trades at 25.5 times earnings (in line with the Nasdaq-100 index) at the end of fiscal 2029 and its earnings per share reach $16.06, its stock price will reach $409. That's double Nvidia's current stock price, indicating that this tech bellwether remains a solid investment, as the impending arrival of Vera Rubin can give its growth and stock price a nice shot in the arm.
Key Takeaways AT&T reports Q2 earnings on July 22, with the model indicating a likely earnings beat.T expanded enterprise connectivity, connected car services and flexible consumer wireless offerings.AT&T is investing in fiber expansion, but intense telecom remain a challenge. AT&T Inc. (T - Free Report) is scheduled to report second-quarter 2026 earnings on July 22, before the opening bell. The Zacks Consensus Estimate for revenues and earnings is pegged at $32.04 billion and 59 cents per share, respectively. The earnings estimate for AT&T for 2026 has increased 0.43% to $2.32 per share over the past 60 days, while the same for 2027 has increased 0.79% to $2.55 per share.
Image Source: Zacks Investment Research
Earnings Surprise HistoryThe communications service provider delivered a trailing four-quarter earnings surprise of 5.19%, on average.
Image Source: Zacks Investment Research
Earnings WhispersOur proven model predicts a likely earnings beat for AT&T for the second quarter. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the chances of an earnings beat. This is exactly the case here. AT&T currently has an ESP of +4.83% and a Zacks Rank #3.
You can see the complete list of today’s Zacks #1 Rank stocks here.
You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.
Factors Shaping the Upcoming ResultsDuring the quarter, AT&T strengthened its enterprise connectivity portfolio with several strategic initiatives. The company launched North America's first Post-Quantum Cryptography (PQC)-enabled Software-Defined Wide Area Network (SD-WAN) service in collaboration with Cisco. The solution is designed to help enterprises protect sensitive data against emerging quantum computing-related cyber threats.
The company also expanded its connected vehicle ecosystem by extending its collaboration with Cisco and LiveOne. The enhanced Connected Car platform integrates in-vehicle connectivity with digital entertainment services. Such innovative product launches are expected to have a positive impact on upcoming results.
In the to be reported quarter, the company continued to expand its consumer connectivity offerings by introducing the Unlimited Day Pass for eligible iPad users. The on-demand service provides flexible wireless connectivity without requiring a long-term subscription.
AT&T also reaffirmed its long-term commitment to fiber and wireless expansion by announcing a $19 billion investment in California through 2030. The initiative aims to extend fiber connectivity to more than 4 million additional households and businesses.
However, AT&T continues to face intense competition in the U.S. telecom market from Verizon Communications, Inc. (VZ - Free Report) and Charter Communications (CHTR - Free Report) . This could limit subscriber additions and weigh on revenue growth.
Price PerformanceOver the past year, AT&T has declined 17.5% against the industry’s growth of 83.2%, outperforming its peers like Charter but underperforming Verizon. Charter has declined 65%, while Verizon has improved 8.8% during this period.
Image Source: Zacks Investment Research
Key Valuation MetricFrom a valuation standpoint, AT&T appears to be trading relatively cheaper than the industry and below its mean. Going by the price/earnings ratio, the company shares currently trade at 9.03 forward earnings, lower than 44.18 for the industry and the stock’s mean of 11.4
Image Source: Zacks Investment Research
Investment ConsiderationsAT&T is aggressively expanding its fiber footprint. The company has reached more than 37 million fiber locations, the highest in America. It is aiming to expand this footprint to more than 60 million locations by the end of the decade. Fiber is emerging as a critical component for AI native connectivity, cloud applications, streaming, gaming, enterprise workloads and next-generation digital experiences. Amid this backdrop, AT&T’s continuous investment in developing a robust fiber architecture nationwide will likely bring long-term benefits.
However, the U.S. telecom market is highly competitive. Major rivals like Verizon and Charter are also aggressively investing in fiber, fixed wireless access, and customer acquisition. T must continue offering attractive pricing, bundled services and network improvements to maintain subscriber growth. In the wireless domain, T-Mobile is also rapidly expanding its 5G network. This could pose a threat to AT&T’s wireless subscriber growth.
It has been implementing several initiatives to drive customer retention over the past several quarters. Its convergence strategy has become one of the central pillars of these retention efforts. The company is focused on increasing the number of households that subscribe to both AT&T wireless and broadband services, including AT&T Fiber and AT&T Internet Air.
When customers get dependent on multiple services from a single vendor, it becomes difficult for them to change service providers. From a user’s point of view, opting for fiber and wireless services from a single vendor reduces complexity for them as well. This trend improves customer retention, lowers churn and increases long-term customer value.
AT&T continues to experience steep declines in legacy wireline and copper-based services as customers migrate to newer technologies. The company's long-term growth story relies on massive investments in fiber and wireless infrastructure. It is accelerating fiber deployment, investing $19 billion in California alone through 2030, which places pressure on free cash flow.
End NoteAT&T continues to invest in fiber and 5G to expand advanced Internet reach and drive more households to buy wireless and home Internet together. Management expects fiber reach to grow by about 8 million locations in 2026, including over 4 million locations acquired from Lumen, and remains on track to reach over 40 million total fiber locations by the end of 2026. The effort of portfolio expansion and venture into new high-growth markets, such as network security and automotive, is a positive.
However, the U.S. wireless market remains saturated. This makes the market highly price sensitive and limits average revenue per user growth. Amid stiff competition from other major players, the company has to continuously invest in network upgrades and improve customer experience to maintain its market share, which impacts profitability. With a Zacks Rank #3 (Hold), AT&T appears to be treading in the middle of the road, and new investors could be better off if they trade with caution.
, /PRNewswire/ -- Bank of America Corporation today announced the Board of Directors has authorized regular cash dividends on the outstanding shares or depositary shares of the following series of preferred stock:
Series of Preferred Stock
Dividend per Share
or Depositary Share1
Record Date
Payment Date
Floating Rate Non-Cumulative
Preferred Stock, Series E
$0.27234
July 31
August 17
Floating Rate Non-Cumulative
Preferred Stock, Series F
$1,105.52311
August 31
September 15
Adjustable Rate Non-
Cumulative Preferred Stock,
Series G
$1,105.52311
August 31
September 15
Floating Rate Non-Cumulative
Preferred Stock, Series 1
$0.29213
August 15
August 28
Floating Rate Non-Cumulative
Preferred Stock, Series 2
$0.29223
August 15
August 28
Floating Rate Non-Cumulative
Preferred Stock, Series 4
$0.29862
August 15
August 28
Floating Rate Non-Cumulative
Preferred Stock, Series 5
$0.28128
August 1
August 21
Fixed-to-Floating Rate Non-
Cumulative Preferred Stock,
Series FF
$29.37500
September 1
September 15
6.000% Non-Cumulative
Preferred Stock, Series GG
$0.3750000
August 1
August 17
5.375% Non-Cumulative
Preferred Stock, Series KK
$0.3359375
September 1
September 25
5.000% Non-Cumulative
Preferred Stock, Series LL
$0.3125000
September 1
September 17
4.250% Non-Cumulative
Preferred Stock, Series QQ
$0.2656250
August 1
August 17
4.750% Non-Cumulative
Preferred Stock, Series SS
$0.2968750
August 1
August 17
1 Each series of preferred stock, other than Series F and Series G, is represented by depositary shares.
Bank of America
Bank of America is one of the world's leading financial institutions, serving individual consumers, small and middle-market businesses and large corporations with a full range of banking, investing, asset management and other financial and risk management products and services. The company provides unmatched convenience in the United States, serving nearly 70 million clients with approximately 3,500 retail financial centers, approximately 15,000 ATMs (automated teller machines) and award-winning digital banking with approximately 60 million verified digital users. Bank of America is a global leader in wealth management, corporate and investment banking and trading across a broad range of asset classes, serving corporations, governments, institutions and individuals around the world. As the #1 small business lender in the United States (FDIC), Bank of America offers industry-leading support to approximately 4 million small business households through a suite of innovative, easy-to-use online products and services. The company serves clients through operations across the United States, its territories and more than 35 countries and/or jurisdictions. Bank of America Corporation stock (NYSE: BAC) is listed on the New York Stock Exchange.
Investors May Contact:
Lee McEntire, Bank of America
Phone: 1.980.388.6780
[email protected]
Jonathan G. Blum, Bank of America (Fixed Income)
Phone: 1.212.449.3112
[email protected]
Reporters May Contact:
Jocelyn Seidenfeld, Bank of America
Phone: 1.646.743.3356
[email protected]
, /PRNewswire/ -- The Board of Directors of PepsiCo, Inc. (NASDAQ: PEP) today declared a quarterly dividend of $1.48 per share of PepsiCo common stock, a 4 percent increase versus the comparable year-earlier period. Today's action is consistent with PepsiCo's previously announced increase in its annualized dividend to $5.92 per share from $5.69 per share, which began with the June 2026 payment. This dividend is payable on September 30, 2026 to shareholders of record at the close of business on September 4, 2026. PepsiCo has paid consecutive quarterly cash dividends since 1965, and 2026 marked the company's 54th consecutive annual dividend increase.
About PepsiCo
PepsiCo products are enjoyed by consumers more than one billion times a day in more than 200 countries and territories around the world. PepsiCo generated nearly $94 billion in net revenue in 2025, driven by a complementary beverage and convenient foods portfolio that includes Lay's, Doritos, Cheetos, Gatorade, Pepsi-Cola, Mountain Dew, Quaker, and SodaStream. PepsiCo's product portfolio includes a wide range of enjoyable foods and beverages, including many iconic brands that generate more than $1 billion each in estimated annual retail sales.
Guiding PepsiCo is our vision to Be the Global Leader in Beverages and Convenient Foods by Winning with pep+ (PepsiCo Positive). pep+ is our strategic end-to-end transformation that puts sustainability and human capital at the center of how we will create value and growth by operating within planetary boundaries and inspiring positive change for planet and people. For more information, visit www.pepsico.com, and follow on X (Twitter), Instagram, Facebook, and LinkedIn @PepsiCo.
Cautionary Statement
Statements in this release that are "forward-looking statements" are based on currently available information, operating plans and projections about future events and trends. Forward-looking statements inherently involve risks and uncertainties. For information on certain factors that could cause actual events or results to differ materially from our expectations, please see PepsiCo's filings with the Securities and Exchange Commission, including its most recent annual report on Form 10-K and subsequent reports on Forms 10-Q and 8-K. Investors are cautioned not to place undue reliance on any such forward-looking statements, which speak only as of the date they are made. PepsiCo undertakes no obligation to update any forward-looking statements, whether as a result of new information, future events or otherwise.
Lockheed Martin uzavřela s vládou USA dohody na rozšíření výroby Patriot PAC-3, THAAD a PrSM. Firma čeká, že kapacita vzroste v příštích letech zhruba třikrát až čtyřikrát.
Key Takeaways Lockheed Martin signed U.S. agreements to expand Patriot PAC-3, THAAD and PrSM production capacity.LMT expects these agreements to lift production rates by roughly three to four times over the coming years.Lockheed Martin's Missiles and Fire Control sales rose 8.2% on higher missile defense production. Lockheed Martin (LMT - Free Report) appears well positioned to benefit from one of the fastest-growing areas of global defense spending — air and missile defense. With a broad portfolio spanning Patriot PAC-3 interceptors, THAAD, Precision Strike Missile (PrSM) and other advanced missile systems, Lockheed Martin is positioned to capitalize on the long-term modernization cycle.
During the first quarter of 2026, the company signed several long-term framework agreements with the U.S. government to accelerate production of Patriot PAC-3, THAAD and PrSM systems. These agreements provide greater demand visibility and are expected to support investments in production facilities, supplier capacity and workforce expansion. Management expects these initiatives to drive a threefold to fourfold increase in production rates over the coming years.
Lockheed Martin’s Missiles and Fire Control business reported an 8.2% year-over-year increase in sales, driven primarily by higher production on integrated air and missile defense programs, including PAC-3, as well as tactical missile programs such as JASSM, LRASM and PrSM. The growth demonstrates that increasing customer demand is already translating into stronger operating performance.
The broader defense spending environment also remains supportive. The United States and allied nations continue prioritizing integrated air and missile defense as a core national security objective. Increased investments in layered defense architectures, precision strike capabilities and advanced interceptors are expected to remain a key component of defense budgets for years to come. These structural trends could support sustained demand across Lockheed Martin's missile portfolio.
Defense Companies Benefiting From Rising Missile DemandAlong with Lockheed Martin, several other defense companies are also positioned to benefit from growing investments in missile defense and precision weapons, as discussed below:
RTX Corporation (RTX - Free Report) continues to benefit through its role in the Patriot air and missile defense system and its expanding portfolio of advanced missile technologies.
Northrop Grumman (NOC - Free Report) is strengthening its position through missile defense sensors, strategic deterrence programs and next-generation hypersonic technologies.
LMT Stock’s Earnings EstimatesThe Zacks Consensus Estimate for 2026 and 2027 earnings per share indicates a year-over-year improvement of 29.5% and 8.02%, respectively.
Image Source: Zacks Investment Research
LMT Stock Trades at a DiscountIn terms of valuation, LMT’s forward 12-month price-to-sales (P/S) is 1.47X, a discount to the industry’s average of 2.54X.
Image Source: Zacks Investment Research
LMT Stock’s Price PerformanceIn the past six months, the company’s shares have lost 11.8% compared with the industry’s 11.4% decline.
Image Source: Zacks Investment Research
LMT’s Zacks RankThe company currently has a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Royalty Pharma schválila čtvrtletní dividendu ve výši 0,235 USD na kmenovou akcii třídy A za 3. čtvrtletí 2026. Vyplacena bude 10. září 2026 akcionářům, kteří budou zapsáni k 14. srpnu 2026.
July 17, 2026 16:15 ET | Source: Royalty Pharma plc
NEW YORK, July 17, 2026 (GLOBE NEWSWIRE) -- The board of directors of Royalty Pharma plc (Nasdaq: RPRX) has approved the payment of a dividend for the third quarter of 2026 of $0.235 per Class A ordinary share.
The dividend will be paid on September 10, 2026, to shareholders of record at the close of business on August 14, 2026.
About Royalty Pharma plc
Founded in 1996, Royalty Pharma is the largest buyer of biopharmaceutical royalties and a leading funder of innovation across the biopharmaceutical industry, collaborating with innovators from academic institutions, research hospitals and non-profits through small and mid-cap biotechnology companies to leading global pharmaceutical companies. Royalty Pharma has assembled a portfolio of royalties which entitles it to payments based directly on the top-line sales of many of the industry’s leading therapies. Royalty Pharma funds innovation in the biopharmaceutical industry both directly and indirectly – directly when it partners with companies to co fund late-stage clinical trials and new product launches in exchange for future royalties, and indirectly when it acquires existing royalties from the original innovators. Royalty Pharma’s current portfolio includes royalties on more than 35 commercial products, including Vertex’s Trikafta and Alyftrek, GSK’s Trelegy, Roche’s Evrysdi, Johnson & Johnson’s Tremfya, Biogen’s Tysabri and Spinraza, Servier’s Voranigo, AbbVie and Johnson & Johnson’s Imbruvica, Astellas and Pfizer’s Xtandi, Pfizer’s Nurtec ODT, and Gilead’s Trodelvy, and 19 development-stage product candidates. For more information, visit www.royaltypharma.com.
JACKSONVILLE, Fla., July 17, 2026 (GLOBE NEWSWIRE) -- CSX Corp. (NASDAQ: CSX) announced that the Company’s Board of Directors approved a $0.14 per share quarterly dividend on the Company’s common stock. The dividend is payable Sept. 15, 2026, to shareholders of record at the close of business Aug. 31, 2026.
About CSX and its Disclosures
CSX, based in Jacksonville, Florida, is a premier transportation company. It provides rail, intermodal and rail-to-truck transload services and solutions to customers across a broad array of markets, including energy, industrial, construction, agricultural, and consumer products. For nearly 200 years, CSX has played a critical role in the nation's economic expansion and industrial development. Its network connects every major metropolitan area in the eastern United States, where nearly two-thirds of the nation's population resides. It also links approximately 250 short-line railroads and more than 70 ocean, river and lake ports with major population centers and farming towns alike.
This announcement, as well as additional financial information, is available on the Company's website at investors.csx.com. CSX also uses social media channels to communicate information about the company. Although social media channels are not intended to be the primary method of disclosure for material information, it is possible that certain information CSX posts on social media could be deemed to be material. Therefore, we encourage investors, the media, and others interested in the company to review the information we post on Facebook and on X, formerly known as Twitter. The social media channels used by CSX may be updated from time to time. More information about CSX Corporation and its subsidiaries is available at www.csx.com.
Contact:
Matthew Korn, CFA, Investor Relations and Corporate Communications
904-366-4515
Paramount Skydance prodloužila lhůty pro své hotovostní a výměnné nabídky na dluhopisy WBD do 31. července 2026. K 16. červenci bylo přihlášeno 66,16 % a 75,95 % příslušných dluhopisů.
, /PRNewswire/ -- Paramount Skydance Corporation (NASDAQ: PSKY) ("Paramount") today announced the extension of the Expiration Dates in connection with the previously announced (i) offers to purchase (the "Tender Offers" and each, a "Tender Offer") for cash, upon the terms and subject to the conditions set forth in the related offer to purchase (the "Offer to Purchase"), any and all of the identified notes in each series of the Existing Tender Offer Notes (defined by reference to the table set forth below) issued by Discovery Global Holdings, Inc. (formerly WarnerMedia Holdings, Inc.) (the "DGH Issuer") and Discovery Communications, LLC (the "DCL Issuer" and together with the DGH Issuer, each a "WBD Issuer" and collectively the "WBD Issuers"), as applicable, and (ii) offers to exchange (the "Exchange Offers" and each, an "Exchange Offer" and, together with the Tender Offers, the "Offers" and each, an "Offer"), upon the terms and subject to the conditions set forth in the related exchange offer memorandum (the "Offering Memorandum"), any and all of the identified notes in each series of the Existing Exchange Offer Notes (defined by reference to the table set forth below) (together with the Existing Tender Offer Notes, the "Offer Notes") issued by the applicable WBD Issuer for notes to be newly issued by Paramount.
The Expiration Dates for the Tender Offers and Exchange Offers (as defined in each of the Offer to Purchase and Offering Memorandum, respectively) have been extended to 5:00 p.m., New York City time, on July 31, 2026, unless further extended. The Settlement Dates for the Tender Offers and Exchange Offers (as defined in each of the Offer to Purchase and Offering Memorandum, respectively) will occur promptly after the Expiration Date and are currently anticipated to occur in the third quarter of 2026. Paramount anticipates extending the Expiration Date for such Tender Offers and Exchange Offers until such time that would result in the Settlement Dates occurring on or promptly following the closing date of the proposed acquisition (the "Acquisition") by Paramount of Warner Bros. Discovery, Inc. ("WBD"). Tenders of the Offer Notes in the Offers may be withdrawn at any time prior to the Expiration Date. The aforementioned extensions further extend the Expiration Dates previously extended by Paramount on June 12, 2026, June 26, 2026, and July 13, 2026.
As of 5:00 p.m., New York City time, on July 16, 2026, approximately 66.16% and 75.95% of the aggregate principal amount of the Existing Tender Offer Notes and Existing Exchange Offer Notes, respectively, have been validly tendered in the applicable Offers. As Paramount previously announced that it anticipates extending the Offers to align with the closing date of the Acquisition, Paramount does not view these figures to be representative of the final results of the applicable Offers.
Information about each series of Offer Notes eligible to participate in the Offers is summarized below.
Type of Offer
Offer Notes to be Tendered
or Exchanged, as
Applicable
Issuer of Offer Notes
CUSIP No. / Common Code
/ ISIN Eligible to
Participate in the Offers (1)
Aggregate Principal
Amount of Offer Notes
Eligible to Participate in the
Offers (2)
Tender Offer
3.950% Senior Notes due
2028
DCL Issuer
25470D CP2
US25470DCP24
$1,234,458,000
Exchange Offer
4.125% Senior Notes due
2029
DCL Issuer
25470D CQ0
US25470DCQ07
$655,825,000
Exchange Offer
3.625% Senior Notes due
2030
DCL Issuer
25470D CR8
US25470DCR89
$914,183,000
Exchange Offer
5.000% Senior Notes due
2037
DCL Issuer
25470D CS6
US25470DCS62
$453,281,000
Exchange Offer
6.350% Senior Notes due
2040
DCL Issuer
25470D CT4
US25470DCT46
$438,102,000
Exchange Offer
4.950% Senior Notes due
2042
DCL Issuer
25470D CU1
US25470DCU19
$130,366,000
Exchange Offer
4.875% Senior Notes due
2043
DCL Issuer
25470D V91
CV9US25470DC
$141,584,000
Exchange Offer
5.200% Senior Notes due
2047
DCL Issuer
25470D W74
CW7US25470DC
$3,161,000
Exchange Offer
5.300% Senior Notes due
2049
DCL Issuer
25470D X57
CX5US25470DC
$247,860,000
Tender Offer
3.755% Senior Notes due
2027
DGH Issuer
254948 AH5
US254948AH58
254948 AN2
US254948AN27
U25483 AA3
USU25483AA38
$1,189,336,000
Exchange Offer
4.054% Senior Notes due
2029
DGH Issuer
254948 AJ1
US254948AJ15
254948 AP7
US254948AP74
U25483 AB1
USU25483AB11
$1,353,828,000
Exchange Offer
4.279% Senior Notes due
2032
DGH Issuer
254948 AK8
US254948AK87
254948 AQ5
US254948AQ57
$2,691,764,000
Exchange Offer
5.050% Senior Notes due
2042
DGH Issuer
254948 AL6
US254948AL60
254948 AR3
US254948AR31
U25483 AD7
USU25483AD76
$4,104,687,000
Exchange Offer
5.141% Senior Notes due
2052
DGH Issuer
254948 AM4
US254948AM44
254948 AS1
US254948AS14
$949,883,000
Exchange Offer
4.302% Senior Notes due
2030
DGH Issuer
XS3393993285
339399328
€234,382,000
Exchange Offer
4.693% Senior Notes due
2033
DGH Issuer
XS3393994507
339399450
€316,641,000
__________
(1)
No representation is made as to the correctness or accuracy of the identifiers listed in this press release or printed on the Offer Notes. Such identifiers are provided solely for the convenience of the holders.
(2)
Represents the aggregate principal amount of Offer Notes outstanding that are eligible to participate in the Offers.
The Exchange Offers are being made pursuant to an exemption from the registration requirements of the U.S. Securities Act of 1933, as amended (the "Securities Act"), and the rules and regulations of the Securities and Exchange Commission (the "SEC") promulgated thereunder, and are also not being registered under any state or foreign securities laws. Any securities offered pursuant to the Exchange Offers may not be offered or sold in the United States or to any U.S. persons (as defined below) except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act. The Exchange Offers will only be made, and the securities offered pursuant to the Exchange Offers are only being offered and issued, to holders of applicable Existing Exchange Offer Notes who are (a) reasonably believed to be "qualified institutional buyers" as defined in Rule 144A under the Securities Act or (b) not "U.S. persons," as defined in Rule 902 of Regulation S under the Securities Act (such holders, "Eligible Holders"), and only Eligible Holders who have completed and returned the eligibility certification are authorized to receive or review the Offering Memorandum or to participate in the Exchange Offers. The eligibility certification is available electronically at: https://gbsc-usa.com/eligibility/paramount.
General
Each Offer is a separate offer, and each may be individually consummated, amended, extended, terminated, or withdrawn, subject to certain conditions and applicable law, at any time in Paramount's sole discretion, and without also consummating, amending, extending, terminating, or withdrawing any other Offer with respect to any other series of Offer Notes. Paramount may terminate an Offer if any of the conditions of such Offer described in the Offer to Purchase or Offering Memorandum, as applicable, are not satisfied or waived by the applicable Expiration Date, subject to applicable law. In addition, Paramount may waive the conditions to an Offer without extending such Offer in accordance with applicable law.
The Offers are being made solely by Paramount and are not being made by WBD or the WBD Issuers. None of Paramount, WBD, the WBD Issuers, the Dealer Managers, the Exchange Agent (as defined below), the Information Agent (as defined below), the trustees under each of the indentures governing the Offer Notes, the trustee or collateral agent under the indenture that will govern the notes to be issued in the Exchange Offers, or any affiliate of any of them makes any recommendation as to whether any holder of Offer Notes should tender or refrain from tendering all or any portion of the principal amount of such holder's Offer Notes for cash or notes to be issued in the Exchange Offers. No one has been authorized by any of them to make such a recommendation. Holders must make their own decision whether to tender Offer Notes in any Offer and, if so, the amount of Offer Notes to tender.
Only Eligible Holders may receive a copy of the Offering Memorandum and participate in the Exchange Offers. Paramount has engaged Global Bondholder Services Corporation to act as the exchange agent (in such capacity, the "Exchange Agent") and information agent (in such capacity, the "Information Agent") for the Offers. Questions concerning the Offers, or requests for additional copies of the Offer to Purchase or Offering Memorandum or other related documents, may be directed to Corporate Actions by telephone at (855) 654-2014 (U.S. toll-free) or (212) 430-3774 (banks and brokers) or by email at [email protected]. Holders should also consult their broker, dealer, commercial bank, trust company or other institution for assistance concerning the Offers. The Exchange Offer documents and the Tender Offer documents can be accessed at the following link: https://gbsc-usa.com/paramount.
Paramount has engaged BofA Securities and Citigroup as dealer managers (in such capacity, the "Dealer Managers") for the Offers. Holders with questions regarding the Offers should contact BofA Securities, Inc. at +1 (888) 292-0070 (toll-free) or +1 (980) 388-3646 (collect) or [email protected] or Citigroup Global Markets Inc. at +1 (800) 558-3745 (toll-free) or +1 (212) 723-6106 or [email protected]. Latham & Watkins LLP is serving as legal counsel to Paramount and Cahill Gordon & Reindel LLP is serving as legal counsel to the Dealer Managers.
This press release is for informational purposes only and does not constitute an offer to sell, or a solicitation of an offer to buy, any security, and does not constitute an offer, solicitation, or sale of any security in any jurisdiction in which such offer, solicitation, or sale would be unlawful.
About Paramount, a Skydance Corporation
Paramount, a Skydance Corporation is a next-generation global media and entertainment company, comprised of three business segments: Studios, Direct-to-Consumer, and TV Media. PSKY's portfolio unites legendary brands, including Paramount Pictures, Paramount Television, CBS, CBS News, CBS Sports, Nickelodeon, MTV, BET, Comedy Central, Showtime, Paramount+, Pluto TV, and Skydance Animation, Film, Television, Interactive/Games, and Paramount Sports Entertainment.
This communication contains "forward-looking statements" regarding the Acquisition and the other transactions referred to herein. The reader is cautioned not to rely on these forward-looking statements. These statements are based on current expectations of future events. If underlying assumptions prove inaccurate or known or unknown risks or uncertainties materialize, actual results could vary materially from the expectations and projections of Paramount. Risks and uncertainties include, but are not limited to: the risk that the closing conditions for the Acquisition will not be satisfied, including the risk that clearances under applicable antitrust or regulatory laws will not be obtained or will be obtained subject to conditions that are not anticipated; the possibility that the transactions described herein will not be completed in the expected timeframe or at all; the occurrence of any event, change or other circumstances that could give rise to the termination of the Acquisition; potential adverse effects to the businesses of Paramount or WBD during the pendency of the Acquisition, such as employee departures or distraction of management from business operations; negative effects of the announcement or the consummation of the Acquisition on the market price of WBD or Paramount stock; the risk of stockholder litigation relating to the Acquisition, including resulting expense or delay; the potential that the expected benefits and opportunities of the Acquisition, if completed, may not be realized or may take longer to realize than expected; risks related to the streaming business of the post-Acquisition combined business (the "Combined Company"); the adverse impact on the Combined Company's advertising revenues as a result of changes in consumer behavior, advertising market conditions, and deficiencies in audience measurement; risks related to operating in highly competitive and dynamic industries; the unpredictable nature of consumer behavior, as well as evolving technologies and distribution models; risks related to the Combined Company's decision to invest in new businesses, products, services, and technologies, and the evolution of the Combined Company's business strategy; the potential for loss of carriage or other reduction in, or the impact of negotiations for, the distribution of the Combined Company's content; damage to the Combined Company's reputation or brands; losses due to asset impairment charges for goodwill, content and long-lived assets, including finite-lived intangible assets; liabilities related to discontinued operations and former businesses; increasing scrutiny of, and evolving expectations for, sustainability initiatives; evolving business continuity, cybersecurity, privacy and data protection and similar risks; challenges in protecting and maintaining the Combined Company's intellectual property rights; domestic and global political, economic and regulatory factors affecting the Combined Company's business generally or the Acquisition; the inability to hire or retain key employees or secure creative talent; disruptions to the Combined Company's operations as a result of labor disputes; risks and costs associated with the integration of, and Paramount's ability to integrate, the businesses of Paramount Global, Skydance Media, LLC, and WBD successfully and to achieve anticipated synergies, including in the amounts or on the timelines anticipated to realize such synergies; litigation related to the Acquisition and other matters or transactions; risks associated with the Combined Company's holding company structure, including its dependence on distributions from its subsidiaries to meet tax obligations and other cash requirements; risks related to our indebtedness, including our substantial outstanding debt obligations, our ability to incur substantially more debt and our ability to meet the financial and other covenants contained in the agreements governing the indebtedness of Paramount, WBD, or the Combined Company. A further list and description of these risks, uncertainties and other factors and the general risks associated with the respective businesses of Paramount and WBD can be found in Paramount's Annual Report on Form 10-K for the fiscal year ended December 31, 2025, filed with the SEC on February 25, 2026, including in the sections captioned "Cautionary Note Concerning Forward-Looking Statements" and "Item 1A. Risk Factors," Paramount's most recently filed Quarterly Report on Form 10-Q for the quarter ended March 31, 2026, filed with the SEC on May 4, 2026, including in the sections captioned "Cautionary Note Concerning Forward-Looking Statements" and "Item 1A. Risk Factors," and Paramount's subsequent filings with the SEC, and in WBD's Annual Report on Form 10-K for the fiscal year ended December 31, 2025, filed with the SEC on February 27, 2026, including in the section captioned "Item 1A. Risk Factors," WBD's Quarterly Report on Form 10-Q for the quarter ended March 31, 2026, filed with the SEC on May 6, 2026, and WBD's subsequent filings with the SEC. Neither Paramount nor WBD undertakes to update any forward-looking statement as a result of new information or future events or developments, except as required by law.
NRG rozšířila texaskou výrobní kapacitu o 456 MW a dokončila nákup 13 GW plynových aktiv, čímž zdvojnásobila výrobní kapacitu na zhruba 25 GW.
Firma také podepsala smlouvy o dodávkách pro datová centra v objemu 445 MW.
Key Takeaways NRG expanded its Texas fleet by 456 MW and is developing plants at Greens Bayou and Cedar Bayou.The company doubled generation capacity to about 25 GW by acquiring 13 GW of natural gas assets. NRG signed 445 MW of data center power deals and is targeting more than 1 GW of additional contracts. NRG Energy (NRG - Free Report) benefits from an expanding generation fleet, positioning the company to capitalize on rising electricity demand and tightening power markets. Its growing capacity can support higher power sales, strengthen margins and create new earnings opportunities.
On June 10, 2026, NRG announced the expansion of its Texas generation fleet to meet rising electricity demand by adding 456 megawatts (MW) at T.H. Wharton and developing new plants at Greens Bayou and Cedar Bayou. The project strengthens NRG’s position in the fast-growing Texas power market and creates opportunities to benefit from rising electricity demand.
In January 2026, NRG completed the acquisition of 13 gigawatts (GW) of natural gas generation assets, doubling its generation capacity to approximately 25 GW. The acquisition added 18 flexible natural gas facilities across Texas and the Northeast. This expanded fleet can help the company serve growing demand while benefiting from potentially stronger power prices. NRG also partners with Sunrun to expand Texas distributed energy solutions, adding dispatchable capacity and advancing its goal of developing a 1 GW virtual power plant by 2035.
The company’s growing fleet also creates opportunities to serve large commercial customers. NRG has signed 445 MW of long-term data center power agreements and is targeting more than 1 GW of additional contracts through its Bring Your Own Power strategy.
Overall, NRG’s expanded generation platform, new Texas capacity and data center opportunities could support long-term earnings growth.
Robust Generation Portfolio Supports Utility GrowthA diversified generation portfolio spanning natural gas, nuclear, coal and renewables strengthen reliability and provides flexibility to meet growing electricity demand. This balanced mix also helps mitigate fuel-price volatility and supports stable earnings and sustainable long-term growth.
Duke Energy (DUK - Free Report) benefits from a diversified generation portfolio spanning natural gas, nuclear, coal, hydroelectric power and renewables. This balanced mix supports a reliable electricity supply, enhances operational flexibility and helps drive long-term earnings growth through fuel diversity.
Vistra Corp. (VST - Free Report) benefits from a diversified generation portfolio comprising natural gas, nuclear, coal, solar and battery storage assets. This broad asset mix enhances operational flexibility, supports rising electricity demand and strengthens the company’s potential for sustainable long-term earnings growth.
The Zacks Rundown on NRGNRG’s Earnings EstimatesThe Zacks Consensus Estimate for 2026 and 2027 EPS indicates a year-over-year increase of 9.67% and 27.89%, respectively.
Image Source: Zacks Investment Research
NRG’s Returns on Equity (ROE)NRG Energy's trailing-12-month ROE is 70.67%, ahead of the industry average of 11.21%.
Image Source: Zacks Investment Research
NRG’s Stock Price PerformanceIn the past month, the company’s shares have plunged 3.1% against the industry’s 2.2% growth.
CWT plánuje v roce 2026 investice ve výši 627 milionů USD a v roce 2027 ve výši 667 milionů USD do infrastruktury. Schválený plán Cal Water za 1,45 miliardy USD má umožnit zvyšování ročních výnosů v letech 2026, 2027 a 2028.
Key Takeaways CWT plans $627 million in 2026 and $667 million in 2027 for infrastructure upgrades.Cal Water's approved $1.45 billion plan allows annual revenues increases through 2028.CWT expects rate base growth above 11.1% annually, exceeding $3.2 billion by 2027. California Water Service Group (CWT - Free Report) is benefiting from strategic investments that support the upgrade and replacement of aging infrastructure. These investments focus on improving system reliability, enhancing water quality and boosting operational efficiency, thereby strengthening service delivery.
The company plans to invest $627 million in 2026 and $667 million in 2027, respectively, to support rate base expansion and sustainable long-term earnings growth. These investments strengthen infrastructure, support PFAS treatment, improve efficiency, enhance water system reliability and address quality requirements.
Recently, CWT’s subsidiary, Cal Water, received approval from the California Public Utilities Commission to invest $1.45 billion through 2027 in water quality, system reliability, power-outage resilience, cybersecurity and long-term water supply projects. The decision allows the company to increase annual revenues by $90.5 million in 2026, $43.2 million in 2027 and $48.9 million in 2028.
CWT expects infrastructure and other capital investments to support a more than 11.1% compound annual rate base growth, with the rate base projected to exceed $3.2 billion by 2027.
The company’s planned acquisition of water and wastewater systems could expand its customer base and create additional infrastructure investment opportunities. Overall, continued capital spending, regulatory support and rate-base growth could provide a strong foundation for sustainable earnings growth, although regulatory approvals, financing costs and execution risks remain important considerations.
Aging Water Utility Infrastructure Calls for UpgradesAs per the U.S Environmental Protection Agency, nearly $1.25 trillion will be needed over the next 20 years for water and wastewater infrastructure improvements. Aging water infrastructure creates investment opportunities as utilities replace old pipelines, upgrade treatment facilities and improve system reliability
American Water Works (AWK - Free Report) continues to invest in upgrading, expanding and maintaining its water and wastewater infrastructure. The company plans to spend $3.7 billion in 2026 and $19-$20 billion from 2026 through 2030 to support system reliability and long-term growth.
American States Water (AWR - Free Report) plans to invest $185-$225 million in 2026 to strengthen and improve infrastructure, support rate base growth and create long-term financial opportunities.
The Zacks Rundown on CWTCWT’s Earnings EstimatesThe Zacks Consensus Estimate for 2026 and 2027 EPS indicates a year-over-year increase of 19.07% and 7.03%, respectively.
Image Source: Zacks Investment Research
Debt to CapitalCWT's debt-to-capital ratio currently stands at 50.29%, lower than the Zacks Utility- Water Supply industry’s 54.63%.
Image Source: Zacks Investment Research
CWT’s Stock Price PerformanceIn the past month, the company’s shares have risen 13.6% compared with the industry’s 8.6% growth.
Zano, a privacy-centric blockchain that has been quietly building since 2019, just pulled the curtain back on Zenith, a new consensus protocol that will move the entire network from its hybrid proof-of-work/proof-of-stake setup to a pure proof-of-stake model.
The announcement, made on July 16, positions Zenith as the most significant architectural change in Zano’s history. A full network transition is targeted for 2027, with no specific activation date locked in yet. In the meantime, the project has a more immediate milestone on the calendar: Hard Fork 6, expected to activate around August 25-27, which will introduce new gateway addresses to the ecosystem.
What Zenith actually changes Zenith cuts target block time from 60 seconds down to approximately 15 seconds. Recommended confirmations drop from 10 to just 4-6, which means typical confirmation times land somewhere in the 60- to 90-second range.
First, all transaction fees will be burned. Not partially redistributed to validators, not sent to a treasury. Burned. Every fee paid on every transaction gets permanently removed from the circulating supply.
Advertisement
Second, the protocol is moving to a lower block reward emission schedule. Validators will still earn rewards for producing blocks, but those rewards will be smaller than what miners and stakers received under the hybrid model.
Third, Zenith introduces what the team calls “ephemeral blocks” to optimize chain size and efficiency, designed to prevent the blockchain from bloating as transaction volume increases.
Privacy stays private Zano solved the challenge of private staking with Zarcanum, a protocol the team developed that enables fully private staking. Stake amounts remain hidden, and block production is non-linkable, meaning observers cannot connect a specific validator to a specific block. Zenith builds directly on top of this foundation, so the transition to pure PoS does not compromise any of the privacy guarantees that already exist.
The project has been working on this in collaboration with Common Prefix, a blockchain research and development firm.
The broader context for privacy chains Zano’s mainnet launched in 2019 with a hybrid consensus model that let users both mine and stake. The shift to pure PoS simplifies that architecture, removing two consensus mechanisms, two potential attack vectors, more complicated upgrade paths, and higher overhead for node operators.
What this means for investors The combination of burned transaction fees and reduced block rewards creates a dual supply reduction mechanism. Moving entirely off proof-of-work also eliminates the energy-intensive mining component.
The Hard Fork 6 activation in late August will serve as an immediate proving ground for the team’s ability to execute network upgrades on schedule, with gateway addresses being introduced as the primary change in that fork.
Disclosure: This article was edited by Editorial Team. For more information on how we create and review content, see our Editorial Policy.
Newmark získal dlouhodobou správu nemovitostí a projektů pro 601W Companies u více než 21 milionů čtverečních stop kancelářských aktiv v USA. Portfolio zahrnuje Chicago, New York, New Jersey a Los Angeles.
, /PRNewswire/ -- Newmark Group, Inc. (Nasdaq: NMRK) ("Newmark" or the "Company"), a leading commercial real estate advisor and service provider to large institutional investors, global corporations and other owners and occupiers, today announced the Company has secured a long-term Property and Project Management assignment with leading institutional investor and developer 601W Companies, expanding the relationship through management of more than 21 million square feet of premier office assets across the U.S., including Chicago, New York, New Jersey and Los Angeles.
Newmark secured the assignment through a coordinated effort led by Jesse Van Dyke, Executive Vice President, Midwest Regional Market Leader, and Richard Holden, President, Property Management, who worked closely with 601W Companies to develop a customized program aligned with 601W Companies' operating philosophy, long-term growth objectives and evolving portfolio needs.
"This assignment reflects the continued execution of our strategy to expand Newmark's recurring revenue businesses while deepening relationships with many of the industry's most sophisticated owners," said Luis Alvarado, Chief Operating Officer. "Property management and project management are critical components of our fully integrated platform, creating opportunities to deliver long-term value for clients while strengthening the breadth and durability of our Investor Solutions business."
The 601W portfolio comprises more than 12 million square feet in Chicago and more than nine million additional square feet across key U.S. markets, including New York City, New Jersey and Los Angeles. Newmark has already begun providing services for 601W's property at 333 S Grand Avenue in Los Angeles.
"601W has been one of the most active buyers of commercial real estate in the United States over the past several years, having acquired or contracted to acquire more than 10 million square feet," said Holden. "That level of conviction reflects exactly the kind of forward-looking ownership we're proud to support."
Newmark will serve as a strategic operating partner across the portfolio, delivering customized Property and Project Management services through an integrated program designed to support 601W Companies' ownership objectives, enhance tenant experiences and drive operational performance across the portfolio.
"Having proactively managed our portfolio through COVID — including restructuring and extending financings across our assets — we are well positioned for long-term growth and focused firmly on the opportunities ahead. We were looking for a strategic partner with the platform, talent and flexibility to match that ambition, and we are excited to work with Newmark on our path forward," said Mark Karasick, Managing Member of 601W. "Newmark brings a level of professionalism and discipline, along with a customized operating model and a collaborative approach, that aligns with our objectives today while providing the scale to grow with us as we continue investing in premier assets across the country."
The assignment further reinforces the Company's ability to serve institutional owners with complex, high-profile portfolios across the United States and reflects continued momentum within Newmark's Management Services businesses, particularly in Chicago, where the portfolio has a significant presence.
"With a significant concentration of assets in Chicago and major holdings across other U.S. markets, this assignment highlights the value of combining deep local market knowledge with the resources and capabilities of our global platform," said Van Dyke. "We're proud to support one of the industry's leading owners and deliver a tailored operating model for a portfolio of this size and complexity."
About Newmark
Newmark Group, Inc. (Nasdaq: NMRK), together with its subsidiaries ("Newmark"), is a world leader in commercial real estate, seamlessly powering every phase of the property life cycle. Newmark's comprehensive suite of services and products is uniquely tailored to each client, from owners to occupiers, investors to founders, and startups to blue-chip companies. Combining the platform's global reach with market intelligence in both established and emerging property markets, Newmark provides superior service to clients across the industry spectrum. For the twelve months ended March 31, 2026, Newmark generated revenues of more than $3.4 billion. As of March 31, 2026, Newmark and its business partners together operated from over 185 offices with more than 9,600 professionals across four continents. To learn more, visit nmrk.com or follow @newmark.
Discussion of Forward-Looking Statements about Newmark
Statements in this document regarding Newmark that are not historical facts are "forward-looking statements" that involve risks and uncertainties, which could cause actual results to differ from those contained in the forward-looking statements. These include statements about the Company's business, results, financial position, liquidity, and outlook, which may constitute forward-looking statements and are subject to the risk that the actual impact may differ, possibly materially, from what is currently expected. Except as required by law, Newmark undertakes no obligation to update any forward-looking statements. For a discussion of additional risks and uncertainties, which could cause actual results to differ from those contained in the forward-looking statements, see Newmark's Securities and Exchange Commission filings, including, but not limited to, the risk factors and Special Note on Forward-Looking Information set forth in these filings and any updates to such risk factors and Special Note on Forward-Looking Information contained in subsequent reports on Form 10-K, Form 10-Q or Form 8-K.
Harmony Biosciences oznámila předběžné tržby z Wakix za 2Q 2026 ve výši 261 mil. USD, meziročně o 30 % vyšší. Zároveň potvrdila celoroční výhled tržeb 1,0–1,04 mld. USD.
Key Takeaways Harmony Biosciences reported about $261M in preliminary Q2 2026 Wakix net product revenues, up 30% Y/Y.HRMY reaffirmed 2026 net product revenue guidance of $1.0-$1.04B after a strong first half.HRMY advances pitolisant programs and named an interim finance chief after its CFO stepped down. Harmony Biosciences (HRMY - Free Report) announced preliminary second-quarter 2026 results.
The company registered a record $261 million in net product revenues from its lead drug, Wakix (pitolisant).
Wakix received FDA approval in August 2019 to treat excessive daytime sleepiness (EDS) in adults with narcolepsy and was launched in the United States in November 2019. In October 2020, the FDA expanded its approval to include the treatment of cataplexy in adults with narcolepsy.
Revenues increased 30% year over year and 21% sequentially from the first quarter, reflecting continued strong demand and solid commercial execution.
Encouraged by its first-half performance, the company reiterated its full-year 2026 net product revenue guidance of $1.0 billion to $1.04 billion, signaling confidence in sustained growth for the remainder of the year.
Harmony is scheduled to report its complete second-quarter 2026 financial results and provide a business update on Aug. 4, 2026.
Shares of HRMY have lost 10.4% year to date against the industry’s 1.7% gain.
Image Source: Zacks Investment Research
HRMY’s CFO Steps DownHarmony announced that chief financial officer (CFO) Glenn Reicin has stepped down, effective July 16, 2026, to pursue other opportunities.
The company appointed Stephen Mollichella, currently senior vice president and controller, as interim principal financial officer while it conducts a search for a permanent CFO.
HRMY’s Efforts to Strengthen BusinessHarmony is pursuing label expansion opportunities for pitolisant beyond narcolepsy, targeting rare neurological disorders such as Prader-Willi syndrome (PWS) and myotonic dystrophy type 1 (DM1).
The company is conducting the phase III TEMPO study in PWS, supported by FDA alignment, which has the potential to serve as the registrational trial and support the company’s efforts to seek pediatric exclusivity for pitolisant.
The FDA granted Orphan Drug designation to pitolisant for the treatment of PWS in 2024.
In DM1, phase II data demonstrated meaningful improvements in EDS and fatigue, supporting further development.
Wakix has also expanded into the pediatric narcolepsy market, with FDA approval for EDS in 2024.
In February 2026, the FDA also approved Wakix for the treatment of cataplexy in patients six years and older with narcolepsy, providing additional long-term growth opportunities for the franchise.
Meanwhile, Harmony is advancing two next-generation formulations of pitolisant to strengthen and extend this franchise.
The company is on track to submit a new drug application for pitolisant GR (gastro-resistant) shortly. A decision from the FDA is expected in the first quarter of 2027. The formulation features an enteric coating designed to reduce gastrointestinal side effects, allowing patients to start treatment at a therapeutic dose without titration. Harmony has filed utility patents that could extend the pitolisant franchise into the 2040s.
HRMY is also developing pitolisant HD (high dose) to further expand the franchise. Phase III studies are underway in narcolepsy (ONSTRIDE 1) and idiopathic hypersomnia (ONSTRIDE 2), with top-line data expected in 2027. The enhanced formulation is designed to improve efficacy through optimized pharmacokinetics, an enteric coating and a higher dose, while supporting differentiated labeling for fatigue in narcolepsy and sleep inertia in idiopathic hypersomnia. Utility patents for Pitolisant HD have also been filed, supporting franchise protection into the 2040s.
HRMY’s Zacks Rank and Other Stocks to Consider HRMY currently carries a Zacks Rank #1 (Strong Buy). A couple of other top-ranked stocks from the sector are Liquidia Corporation (LQDA - Free Report) and Novavax (NVAX - Free Report) , each sporting a Rank #1 at present. You can see the complete list of today’s Zacks #1 Rank stocks here.
Over the past 60 days, estimates for Liquidia’s 2026 earnings per share (EPS) have increased from $2.97 to $3.02. Over the same period, EPS estimates for 2027 have also increased from $4.81 to $4.92. LQDA shares have skyrocketed more than 118.3% year to date.
Liquidia’s earnings beat estimates in three of the trailing four quarters and missed in the remaining one, with the average surprise being 54.40%.
Over the past 60 days, estimates for Novavax’s 2026 loss per share have narrowed from 20 cents to 19 cents. Over the same period, loss per share estimates for 2027 have narrowed from 31 cents to 25 cents. NVAX shares have gained nearly 22.7% year to date.
Novavax’s earnings beat estimates in each of the trailing four quarters, with the average surprise being 305.24%.
Akcie GMED za poslední rok vzrostly o 43,6 % díky silnému růstu U.S. Spine a Enabling Technologies. Výnosy Enabling Technologies v 1. čtvrtletí meziročně stouply o 21,1 %.
Key Takeaways GMED gained 43.6% in a year, outperforming its industry and the S&P 500 on strong business momentum. GMED saw U.S. Spine and Enabling Technologies growth, with Enabling Technologies revenues up 21.1%. GMED remains debt-free with strong operating cash flow, despite higher SG&A and currency headwinds. Globus Medical (GMED - Free Report) shares have surged 43.6% over the past year, showing impressive momentum. It has significantly outperformed the industry’s 6.5% decline and the S&P 500 composite’s 23.8% gain.
With healthy fundamentals and strong growth opportunities, this Zacks Rank #3 (Hold) company appears to be a solid wealth creator for its investors at the moment.
Based in Audubon, PA, Globus Medical develops and commercializes healthcare solutions for patients with musculoskeletal disorders. The company has two major product categories — Musculoskeletal Solutions and Enabling Technologies. Musculoskeletal Solutions primarily consists of implantable devices, biologics, accessories and unique surgical instruments, used in an expansive range of spinal, orthopedic and neurosurgical procedures. Enabling Technologies is an advanced computer-assisted intelligent system that’s designed to enhance surgeons’ capabilities and streamline complicated surgical procedures for both patients and caregivers.
Key Catalysts for GMED’s GrowthGlobus Medical’s share price is trending upward, prompted by strong prospects in both the reporting segments. Within the Musculoskeletal arm, in the first quarter, U.S. Spine business marked its third straight quarter of 10% growth, with double-digit growth cited across standard fixation, minimally invasive surgery pedicle screws, expandable transforaminal lumbar interbody fusion, anteriorlumbar interbody fusion, posterior cervical and cervical plating. Trauma revenue growth was driven by continued adoption of the core trauma portfolio and the Precice limb-lengthening portfolio, while the ANTHEM Elbow system continued to exceed expectations.
Within the Enabling Technologies arm, ExcelsiusGPS platform continues to support implant pull-through and cross-selling as surgeons adopt a more integrated workflow. The company also carries out continued deal activity with a mix shift toward leases and rentals versus outright sales. In the first quarter, Enabling Technologies’ revenues increased 21.1% year over year.
Investors are also impressed with its investment in R&D and product cadence, which acts as a core part of its competitive positioning. Consistent with this strategy, first-quarter R&D expenses accounted for 4.8% of sales. Management expects R&D spending to reach 5% to 6% of net sales for the full year, with investments increasing methodically as product development efforts progress.
The company’s early second-quarter FDA 510(k) clearances for patient-specific lumbar spacers and rods further support its strategy of integrating planning software, enabling technologies, and implants into a unified workflow, a move that could strengthen account relationships and increase procedure-level pull-through over time.
Globus Medical ended the first quarter of 2026 with $560.9 million of cash and cash equivalents and $68.9 million of short-term marketable securities. The company remains debt-free. Liquidity is also being replenished internally, with $202.4 million of operating cash flow generated in the quarter. This supports continued capital spending and buybacks alongside ongoing integration work.
Image Source: Zacks Investment Research
Factors That May Offset GMED’s GainsThe company operates in an environment of interest-rate uncertainty, inflation and geopolitical complexity that can disrupt supply chains and raise input costs. SG&A was $297.8 million in first-quarter 2026, or 39.2% of sales, up from $242.8 million a year earlier, reflecting higher compensation and benefit costs on higher volume.
Additionally, Globus Medical recorded a $2.1 million foreign currency transaction loss in the first quarter, which directly affected other income and expenses. With foreign revenues and expenses concentrated across regions such as Japan, the Eurozone, the United Kingdom and Australia, currency volatility can also affect gross margin and operating expense leverage over time.
A Glance at GMED’s EstimatesIn the past 30 days, the Zacks Consensus Estimate for 2026 earnings per share (EPS) has remained unchanged at $4.74.
Revenues are projected to grow 8.7% to $3.20 billion in 2026, while the same for 2027 is expected to reach $3.41 billion (up 6.6%).
Key PicksSome better-ranked stocks in the broader medical space are Alcon (ALC - Free Report) , Integra LifeSciences (IART - Free Report) and Phibro Animal Health (PAHC - Free Report) .
Alcon has an earnings yield of 5.1% against the industry’s negative 2.8% yield. Shares of the company have gained 22.8% compared with the industry’s 4.8% growth. ALC’s earnings topped estimates in three of the trailing four quarters and missed in one, the average surprise being 3.7%.
ALC carries a Zacks Rank #2 (Buy) at present. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Integra LifeSciences, carrying a Zacks Rank #2 at present, has an earnings yield of 16% against the industry’s negative 3% yield. Shares of the company have gained 22.8% compared with the industry’s 4.8% growth. IART’s earnings topped estimates in each of the trailing four quarters, the average surprise being 16.8%.
Phibro Animal Health, carrying a Zacks Rank #2 at present, has an earnings yield of 9.2% compared with the industry’s 2.8% yield. Shares of the company have climbed 43.1% against the industry’s 27.9% decline. PAHC’s earnings beat estimates in each of the trailing four quarters, the average surprise being 16.3%.
The Euro to Dollar (EUR/USD) exchange rate is trading around 1.1440 after recovering from June lows near 1.1325, but Goldman Sachs believes options markets are signalling renewed downside risks for the pair.
EUR/USD has remained relatively stable through July, gaining around 0.3% so far this month after falling more than 2% in June.
Goldman Sachs highlights developments in the options market, particularly swaptions, as a warning that investors may be preparing for greater downside exposure in the Euro-Dollar pair.
The bank argues that while EUR/USD has been supported by a period of Dollar weakness and reduced expectations for aggressive Federal Reserve tightening, the balance of risks has become less favourable for the Euro.
A key concern is that markets may have become too comfortable with the recent range-bound environment. Renewed volatility, changes in interest-rate expectations or a return of Dollar demand could quickly challenge EUR/USD support.
Goldman Sachs continues to monitor the interaction between rates markets and currency positioning, with options pricing suggesting investors are increasingly willing to protect against a move lower.
The Euro also faces challenges from the broader macro backdrop. While expectations for further European Central Bank tightening have provided some support, growth concerns and energy-related risks remain potential headwinds.
With EUR/USD currently holding close to the 1.14 area, Goldman Sachs sees the options market as highlighting the possibility that the next significant move could be lower rather than a continuation of the recent recovery.
Doximity rychle rozšiřuje AI: téměř polovina aktivních předepisujících už používá jeho nástroje a Clinical AI Suite má 140 zdravotnických systémů. Firma ale očekává, že investice do AI ve fiskálním roce 2027 stlačí marže z 55 % ve fiskálním roce 2026 na přibližně 49 %.
Key Takeaways DOCS is expanding AI with rising physician use and early AI Search contracts with top-20 pharma companies.Doximity's Clinical AI Suite now serves 140 health systems, supporting retention and cross-selling.DOCS expects AI investment to trim margins as regulatory reviews delay meaningful revenue contribution. Doximity (DOCS - Free Report) is entering a pivotal phase as it accelerates investments in artificial intelligence to expand beyond its core physician engagement platform. While robust physician adoption, growing enterprise AI deployments and exceptional cash generation strengthen its long-term outlook, a sluggish pharma advertising market, rising AI investments and commercialization risks could temper near-term financial performance.
Shares of this Zacks Rank #3 (Hold) company have lost 49.8% so far this year compared with the industry's 5.6% decline and the S&P 500 Index’s 10.9% rise.
Doximity, with a market capitalization of $4.07 billion, is a global specialty medical device company.
DOCS’ bottom line is estimated to improve 3.8% over the next five years. Its earnings beat estimates in each of the trailing four quarters, delivering an average surprise of 7.99%.
Image Source: Zacks Investment Research
What's Driving DOCS’ Performance?AI Platform Is Rapidly Becoming Doximity's Next Major Growth Engine: Doximity is positioning artificial intelligence as its largest long-term monetization opportunity. Since acquiring Pathway, AI Search and AI Scribe users have tripled, while nearly half of all active prescribers now use the company's AI tools.
Management has already signed its first AI Search contracts with top-20 pharmaceutical companies and believes AI Search alone represents a multibillion-dollar incremental addressable market beyond its existing pharma advertising business. The combination of physician engagement, hospital adoption and early customer interest suggests Doximity is building a differentiated AI ecosystem that could materially expand revenues over the next several years rather than simply enhancing existing products.
Deepening Health System Integration: Doximity's growing integration into hospital workflows is making its platform increasingly indispensable to physicians. Nearly half of all U.S. doctors now work at health systems using Doximity's workflow or scheduling tools, while 140 health systems, including seven of the top 20 U.S. hospitals, have adopted its Clinical AI Suite.
Management emphasized that more than 250,000 prescribers now access AI capabilities through HIPAA-compliant enterprise deployments, creating a significant barrier for competitors. As hospitals increasingly prioritize secure AI environments over public AI tools, Doximity's trusted infrastructure, physician network and enterprise relationships should support higher customer retention and expanding cross-selling opportunities across workflow, telehealth and AI solutions.
Record Physician Engagement: Doximity continues to strengthen the core asset underpinning its business — physician engagement. Workflow usage increased approximately 30% year over year, reaching more than 800,000 quarterly active prescribers, representing one of the strongest engagement accelerations in the company's history. AI usage is growing even faster, with users nearly doubling their monthly query activity since January.
Higher engagement not only strengthens customer loyalty but also increases the value of Doximity's advertising, workflow and AI offerings to pharmaceutical companies and health systems. Management believes sustained engagement growth will eventually translate into stronger revenue expansion, particularly as new AI-powered commercial products become more widely adopted across its physician network.
What’s Weighing on DOCS Stock?Core Pharma Advertising Market Remains Weak: The biggest near-term challenge for Doximity remains the soft healthcare professional (HCP) digital advertising market. Management acknowledged continued policy uncertainty, macroeconomic risks and shorter pharmaceutical budgeting cycles, causing many customers to delay spending commitments and favor shorter-duration contracts.
The company expects the overall HCP digital advertising market to grow only around 5% or less during fiscal 2027, significantly below historical levels. Although Doximity continues to outperform many peers, sluggish industry spending limits visibility and reduces opportunities for traditional advertising growth. Until pharmaceutical companies regain confidence and commit to longer-term marketing budgets, revenue acceleration is likely to remain constrained.
AI Monetization Will Pressure Margins: While AI represents Doximity's largest long-term opportunity, management expects fiscal 2027 to be an investment year rather than a significant earnings contributor. The company plans to substantially increase spending on AI compute, engineering talent, brand marketing, and product development, resulting in adjusted EBITDA margins declining from 55% in fiscal 2026 to approximately 49% in fiscal 2027.
Management also expects minimal AI revenue contribution during the first half because regulatory reviews and customer implementation timelines will delay commercialization. Consequently, the company could face a period of elevated expenses without commensurate revenue growth, increasing execution risk if AI adoption progresses more slowly than anticipated.
Commercial Success Depends on Regulatory and Customer Adoption of AI: Although customer interest in AI Search appears strong, commercialization remains at a very early stage. Management acknowledged that pharmaceutical companies must complete extensive medical, legal and regulatory reviews before campaigns can be deployed, creating longer implementation timelines than traditional advertising products.
Because Doximity launched the commercial offering only recently, management expects most of the financial benefits to materialize in the second half of fiscal 2027. Delays in regulatory approvals, customer onboarding, or campaign execution could defer revenue recognition. Given management's expectation that AI Search will become a major future growth driver, slower-than-expected commercialization would likely weigh on investor expectations.
Estimate TrendThe Zacks Consensus Estimate for fiscal 2027 revenues is pegged at $670.2 million, implying growth of 3.9% from the year-ago reported figure. The consensus mark for adjusted EPS is pinned at $1.39, indicating a decline of 8.6% from the previous year’s recorded level.
In the past 60 days, DOCS’ earnings estimate for fiscal 2027 has remained stable.
Stocks to ConsiderSome better-ranked stocks from the broader medical space are Alcon (ALC - Free Report) , Intuitive Surgical (ISRG - Free Report) and Cardinal Health (CAH - Free Report) , each carrying a Zacks Rank #2 (Buy) at present. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Alcon reported first-quarter 2026 earnings per share of 85 cents, which beat the Zacks Consensus Estimate by 6.3%. Revenues of $2.69 billion surpassed the Zacks Consensus Estimate by 0.3%.
Alcon has an estimated long-term earnings growth rate of 11.5%. ALC’s earnings surpassed estimates in three of the trailing four quarters and missed once, the average surprise being 3.66%.
Intuitive Surgical reported first-quarter 2026 adjusted EPS of $2.50, which beat the Zacks Consensus Estimate by 20.2%. Revenues of $2.77 billion surpassed the Zacks Consensus Estimate by 6.2%.
Intuitive Surgical has an estimated long-term earnings growth rate of 14.3%. ISRG’s earnings surpassed estimates in each of the trailing four quarters, the average surprise being 16.8%.
Cardinal Health reported a third-quarter fiscal 2026 adjusted EPS of $3.17, which beat the Zacks Consensus Estimate by 13.2%. Revenues of $60.94 billion missed the Zacks Consensus Estimate by 2.3%.
Cardinal Health has an estimated long-term earnings growth rate of 17%. CAH’s earnings surpassed estimates in each of the trailing four quarters, the average surprise being 10.3%.
Key Takeaways Reddit is expanding AI through Google and OpenAI partnerships, boosting licensing revenues and relevance. RDDT improved ads, search and feeds with AI, as Q1 2026 search weekly active users rose 30% year over year. Reddit expects Q2 2026 revenues of $715-$725M as AI investments support top-line growth. Reddit (RDDT - Free Report) is benefiting from accelerating momentum in its AI initiative, which is increasingly positioning it as a foundational resource in the modern Internet landscape. With more than 25 billion posts and comments and nearly 500 million weekly users, Reddit’s platform is uniquely positioned to provide real human perspectives, an essential resource for both AI model training and genuine user engagement.
A key driver of this momentum is Reddit’s strategic partnerships with leading AI companies such as Google and OpenAI. These collaborations generate direct licensing revenues and reinforce Reddit’s relevance as a source of high-quality, diverse data for large language models. The company highlighted that it remains the most-cited source in AI citations across platforms, and that its data is among the most-searched on Google.
Reddit is leveraging AI and machine learning to enhance its own platform. The company has invested heavily in machine learning talent and infrastructure, focusing on improving the user experience through better content recommendations, faster onboarding and more relevant feeds. Reddit’s ad stack now integrates AI-driven automation and optimization, resulting in measurable improvements for advertisers, such as a 17% reduction in cost per action and a 25% increase in conversions for those using AI-powered campaign features.
Reddit’s AI-driven product improvements are enhancing user experience and engagement. The company has focused on upgrading its talent and infrastructure, particularly in machine learning, to improve core features such as feed relevance, onboarding and search. In the first quarter of 2026, search weekly active users were up 30% year over year, and new AI-powered features like bot verification and machine translation are making the platform more accessible and secure.
Reddit’s AI strategy is expected to benefit the company by driving its top-line growth. For the second quarter of 2026, management expects revenues to be in the range of $715 million to $725 million.
RDDT Faces Stiff CompetitionRDDT is facing stiff competition from competitors like Meta Platforms (META - Free Report) and Snap (SNAP - Free Report) . Both Meta Platforms and Snap are also expanding their footprint in the AI space.
Meta Platform is benefiting from its accelerating growth into artificial intelligence (AI), which is driving significant top-line growth. Meta Platform’s release of the Muse family of models and the upgraded Meta AI assistant has positioned the company as a leader in personal superintelligence, with billions of users now accessing these AI-powered features. This surge in AI-driven engagement is translating directly into top-line growth, as evidenced by a 33% year-over-year increase in total revenues to $56.3 billion for the first quarter of 2026.
Snap has introduced a suite of AI-powered advertising tools to help brands create, optimize and personalize campaigns on Snapchat. New features include AI-assisted campaign setup, image-to-video generation, creative enhancement, conversational AI Sponsored Snaps and creator marketplace automation, aimed at improving engagement, commerce and advertising performance across its platform.
RDDT’s Share Price Performance, Valuation and EstimatesRDDT shares have plunged 19.4% year to date, underperforming the broader Zacks Computer & Technology sector’s 16.5% appreciation and the Internet - Software industry’s 3.8% decline.
RDDT Stock Performance
Image Source: Zacks Investment Research
RDDT shares are overvalued, with a forward 12-month Price/Sales of 9.32X compared with the Computer & Technology sector’s 6.88X. RDDT has a Value Score of F.
RDDT Valuation
Image Source: Zacks Investment Research
The Zacks Consensus Estimate for 2026 earnings is pegged at $4.83 per share, which has been unchanged over the past 30 days. This suggests 84.35% year-over-year growth.
RDDT currently carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Foundry Digital, a prominent Bitcoin mining pool operator based in Rochester, New York, announced it will allow its mining clients to determine the pool’s signaling stance on the controversial BIP-110 proposal. Clients will cast their votes using their respective hashrate, directly influencing the pool’s action regarding the upgrade.
BIP-110: Restricting non-monetary dataBIP-110, short for Bitcoin Improvement Proposal 110, aims to address the rising volume of arbitrary and non-monetary data being stored on the Bitcoin network. If implemented, the proposal would initiate a soft fork, resulting in backward-compatible rule changes that cap the amount of such data included in transactions.
The proposal is also known as the “reduced data temporary soft fork.” Key rules include limiting most new outputs to 34 bytes, reestablishing an 83-byte limit on OP_RETURN outputs, and prohibiting data pushes above 256 bytes.
Mini dictionary: OP_RETURN, a script opcode in Bitcoin transactions, allows users to store small amounts of arbitrary data on the blockchain, often used for metadata or simple messages.
Supporters contend that these measures would reinforce Bitcoin’s design as a peer-to-peer electronic cash system. Conversely, critics argue the proposal transforms a policy debate into a technical consensus change and could lead to the exclusion of transactions that pay network fees.
“It’s one of the more actively debated proposals in Bitcoin right now, and miners play a direct role in whether it activates,” Foundry stated, stressing the importance of miner participation in network governance.
Among the high-profile opponents are MicroStrategy founder Michael Saylor and Blockstream co-founder Adam Back, who have publicly raised concerns about the implications for transaction validation.
How voting will workFoundry outlined that each participating miner’s vote will be weighted according to their average hashrate on the pool over a 10-day period from July 6 to July 15. The company expects the voting window to remain open until the blockchain reaches block 961,632, projected for early August. At this point, the soft fork’s fate is likely to be decided.
Initially, Foundry’s default position is to signal “No” for BIP-110. However, should “Yes” votes exceed 51% of the hashrate during the voting window, Foundry will shift to signaling “Yes” on all of its future blocks. Any accounts that do not participate are automatically considered “No” votes. Meanwhile, miners retain the right to change their vote as long as the window remains open, with individual choices remaining confidential and only overall results shared.
Market observers note the significance of Foundry’s decision, as the company currently controls roughly one-third of the network’s total hashrate. Analysts at BGeometrics have suggested that the combined actions of leading pools like Foundry and Antpool could decisively move daily signaling metrics into a range capable of determining the soft fork’s fate.
Supporters believe BIP-110 can help Bitcoin function as true peer-to-peer money, while critics worry it may introduce contentious network changes and prevent certain fee-paying transactions from confirming.
ProposalMain Rule ChangeAdvocatesOpponentsBIP-110Limits arbitrary data in transactions; caps OP_RETURN at 83 bytesBitcoin developers, some minersMichael Saylor, Adam BackA final signaling window near block 961,632 will require Foundry to declare its majority-supported position before the activation timeline closes. The outcome will depend on where the majority of hashrate-weighted votes fall at the end of the period.
Disclaimer: The information contained in this article does not constitute investment advice. Investors should be aware that cryptocurrencies carry high volatility and therefore risk, and should conduct their own research.
Americké spot Bitcoin ETF zaznamenaly třetí po sobě jdoucí den čistých přílivů a za tři obchodní seance přidaly 368 milionů USD. Kumulativní přílivy už dosáhly 51,2 miliardy USD.
Exchange-traded funds backed by spot Bitcoin show a new sign of stability after several months marked by capital outflows. In the United States, investors recorded a third consecutive session of net inflows, confirming renewed interest in this category of products. This development comes as the market tries to regain better balance after a difficult start to the year. Meanwhile, data show a gradual improvement in flows, despite a context where price performance remains under pressure.
In brief US spot Bitcoin ETFs recorded 368 million dollars of net inflows in three consecutive sessions. The cumulative inflows of these funds now reach 51.2 billion dollars, with 77.7 billion dollars in assets under management. Bitcoin briefly crossed 65,000 dollars while July flows returned to positive territory. Despite this improvement, spot ETFs still show a net flow deficit of 5.4 billion dollars since the beginning of 2026. Bitcoin: Spot ETFs Post Three Consecutive Sessions of Inflows US spot ETFs linked to Bitcoin recorded 79.2 million dollars of net inflows on Thursday. This performance extends a positive streak after 181 million dollars recorded on Tuesday, then 108 million dollars on Wednesday. In total, these three sessions represent about 368 million dollars of new capital, according to SoSoValue data.
Spot Bitcoin ETFs record several consecutive sessions of net capital inflows, bringing cumulative flows to over 51.2 billion dollars by mid-July 2026. Source: SoSovalue. Moreover, cumulative net inflows since the launch of these products now reach 51.2 billion dollars. Assets under management also increase to reach 77.7 billion dollars. At the same time, the price of bitcoin briefly exceeded the 65,000 dollars threshold on Wednesday, a first since the end of June. This price movement coincided with flows toward ETFs returning to a more favorable trajectory.
Flows Turn Positive After Several Challenging Months Recent investments have allowed monthly flows of spot Bitcoin ETFs to return to positive territory during July. This improvement follows net outflows of 4.51 billion dollars in June and 2.4 billion dollars in May. If this momentum continues until the end of the month, July will become the first positive month since April, during which ETFs recorded 1.97 billion dollars of net inflows.
However, the annual balance remains negative. On Friday, net flows of US ETFs still showed a deficit of about 5.4 billion dollars since the beginning of 2026. At the same time, Bitcoin was trading around $63,400 at the time of writing, a decrease of about 28% since the start of the year. These figures show that the recovery of flows is not yet accompanied by a sustainable return in market performance.
The next sessions will allow verification of whether this investment resurgence is confirmed. Continued inflows could reinforce the momentum observed in ETFs, while bitcoin’s evolution will remain a key indicator to measure the strength of this trend. Market participants will also monitor the funds’ ability to maintain positive flows in the coming weeks.
Maximize your Cointribune experience with our "Read to Earn" program! For every article you read, earn points and access exclusive rewards. Sign up now and start earning benefits.
Join the program
A
A
Lien copié
Ghiles A.
Journaliste et rédacteur web passionné par l’univers des cryptomonnaies et des technologies Web3. J’y traite les dernières tendances et actualités afin de proposer un contenu de haute qualité à un large public du secteur.
DISCLAIMER
The views, thoughts, and opinions expressed in this article belong solely to the author, and should not be taken as investment advice. Do your own research before taking any investment decisions.
Texas provedl první nákup Bitcoinu za zhruba 5 milionů USD přes ETF BlackRock iShares Bitcoin Trust a stal se prvním státem, který skutečně financoval a koupil Bitcoin pro strategickou rezervu.
While federal lawmakers continue to argue over the finer points of digital asset legislation, US states have quietly started putting real money into Bitcoin. Texas executed its first purchase of roughly $5 million in Bitcoin through the BlackRock iShares Bitcoin Trust (IBIT) ETF in late November 2025, making it the first state to actually fund and buy Bitcoin for a strategic reserve.
The purchase came from a $10 million allocation approved under SB 21, which Governor Greg Abbott signed into law in June 2025. Texas acquired its Bitcoin at prices ranging between roughly $87,000 and $91,000 per coin. New Hampshire and Arizona both enacted their own strategic reserve laws months earlier, and over 30 additional states have introduced similar bills as of mid-2026.
The state-level Bitcoin land grab New Hampshire got its law on the books first. HB 302, signed in May 2025, authorized investments in Bitcoin and qualifying digital assets up to certain portfolio limits. Arizona followed almost immediately with HB 2749, also signed in May 2025, which took a slightly different approach by leveraging unclaimed property and seized assets to build its digital holdings.
Texas’s approach of routing the purchase through BlackRock’s IBIT ETF is notable. Rather than setting up custodial infrastructure from scratch, Texas went with the most liquid and institutionally familiar wrapper available.
Advertisement
More than 30 states have introduced Bitcoin reserve-style bills, reflecting bipartisan interest in treating Bitcoin as a reserve asset alongside traditional holdings like gold and bonds.
California’s Digital Financial Assets Law became operative on July 1, 2026, imposing licensing requirements on crypto businesses operating in the state. New York continues refining its BitLicense standards.
Washington’s half-finished homework In March 2025, the Trump administration established a Strategic Bitcoin Reserve through executive order, funded with forfeited Bitcoin already held by government agencies.
In July 2025, the GENIUS Act was signed into law, creating a comprehensive regulatory framework for payment stablecoins. The legislation included reserve requirements, audit mandates, and supervisory guidelines.
The Digital Asset Market Clarity Act, commonly called the CLARITY Act, has advanced through various stages but still hasn’t become law as of mid-2026.
What this means for investors When state treasuries start buying Bitcoin, it changes the asset’s narrative in ways that matter for every market participant. These aren’t hedge funds chasing alpha or retail traders following social media hype. These are government entities making deliberate allocations through regulated vehicles, framed as fiduciary decisions about public funds.
Texas’s $10 million is a rounding error in a state budget that runs into the hundreds of billions. These are test cases, designed to establish legal precedent and operational frameworks that can scale.
Investors watching this space should pay attention to three things: which states move from legislation to actual purchases, whether the CLARITY Act reaches the president’s desk before year-end, and how state-level reserves perform relative to traditional holdings in their first full reporting cycles.
Disclosure: This article was edited by Editorial Team. For more information on how we create and review content, see our Editorial Policy.
Ripple Payments Europe SA byla oficiálně zapsána do registru MiCA u ESMA a získala plnou autorizaci CASP v Evropě. Díky licenci v Lucembursku může Ripple nabízet služby ve všech 30 zemích EHP.
XRP-associated blockchain payment firm Ripple has been officially listed on Europe's MiCA register by the European Securities and Markets Authority (ESMA) following its recent licensing in the region.
The listing comes amid the addition of 14 new crypto firms that have now become fully authorized to operate as licensed crypto asset service providers in Europe.
Ripple Payments Europe gains full CASP authorization Following this development, the European payment arm of the renowned blockchain firm, Ripple Payments Europe SA, has gained full authorization to operate in Europe.
Coupled with its recent licensing in Luxembourg, Ripple can now deliver its crypto services to financial institutions and businesses across all 30 countries of the European Economic Area.
You Might Also Like
With Ripple Payments Europe now added to the MiCA register alongside 14 other crypto firms, the total number of licensed crypto asset service providers (CASPs) in Europe has increased to 294.
XRP in spotlight While this marks a major milestone for Ripple, it has also put its associated crypto assets, including XRP, in the spotlight, as it positions them for broader adoption.
With Ripple fully eligible to deliver its crypto payment services in Europe, Ripple-based token projects XRP, XRPL, and RLUSD are set for stronger real-world use cases.
Evernorth drží přes 470 milionů XRP a chce vstoupit na Nasdaq přes SPAC fúzi pod tickerem XRPN. Projekt podporují Ripple, SBI, Pantera Capital, Kraken a Arrington Capital.
Evernorth, a crypto treasury company, has assembled more than 470 million XRP as part of an ambitious plan to list on the Nasdaq under the ticker “XRPN” through a special purpose acquisition company (SPAC) merger. Dr. Kamilah Stevenson, a wealth educator with expertise in digital assets, highlighted the company’s growing XRP holdings as a signal of increasing institutional conviction in the cryptocurrency.
Institutional strategy behind EvernorthEvernorth’s core model centers on holding XRP on its balance sheet for shareholders, essentially transforming the company into a corporate vault for the digital asset. Once the company is publicly listed, purchasing its shares would give investors indirect exposure to the XRP pool, similar to how some public companies have structured their balance sheets around Bitcoin holdings.
Unlike firms that simply speculate on crypto prices, Evernorth’s stated mission is to remove XRP from circulation and warehouse it for the long term. Dr. Stevenson emphasized that this is a balance-sheet allocation, not a short-term trading play, with all transactions and holdings disclosed in public regulatory filings.
Stevenson noted the distinctive nature of Evernorth’s approach, drawing a comparison to similar strategies used by companies that focus exclusively on Bitcoin. Her analysis pointed out that Evernorth’s model offers institutional investors a new avenue to gain exposure to XRP through equity markets.
Backing and regulatory processMajor industry names have committed to Evernorth, including Ripple—the company behind the XRP Ledger—SBI, Pantera Capital, Kraken, and Arrington Capital. These backers have reportedly pledged more than $1 billion in capital to support the corporate structure.
Evernorth’s proposed Nasdaq listing remains incomplete, as the process still requires regulatory approval and consent from shareholders. Stevenson underlined that the plans are currently in the filing stage with relevant authorities and that no trading of XRPN shares can take place until permissions are secured.
Publicly available filings are being used to transparently document Evernorth’s operations, a process designed to provide both investors and regulators with confidence in the company’s strategy.
Mini dictionary: Special Purpose Acquisition Company (SPAC) – A SPAC is a publicly listed company created for the purpose of acquiring or merging with another company to facilitate taking that company public without a traditional initial public offering (IPO).
Company/BackerRole/ContributionRippleStrategy backer, technology providerSBI (Japan)Strategic investment, capital providerPantera CapitalInstitutional investorKrakenExchange support, possible liquidity partnerArrington CapitalVenture backer, capital commitmentImplications for individual investorsDr. Stevenson, who has significant experience educating on wealth strategies in crypto markets, cautions that Evernorth’s strategy is not directly instructive for retail investors. She distinguishes between the financial engineering available to corporations and the personal risk that comes from borrowing heavily to invest in volatile assets like XRP.
She urges smaller investors to focus on tax-efficient structures, such as maintaining digital assets in tax-advantaged accounts like Roth IRAs. This approach, Stevenson argues, enhances wealth preservation and asset protection without resorting to high leverage or risky borrowing practices.
The goal for individuals, according to Stevenson, should be disciplined asset accumulation and risk management, rather than attempts to mimic sophisticated corporate treasury operations. She also highlights the importance of regulatory compliance and prudent financial planning in the context of crypto wealth management.
Evernorth’s approach to XRP is structured for long-term balance-sheet strength rather than speculative trading, reflecting a conviction-based corporate strategy that public investors will soon be able to access if the listing moves forward.
In summary, while Evernorth’s trajectory may offer institutions and investors a unique channel into XRP exposure, Stevenson makes clear that regulatory processes remain ongoing and retail strategies should prioritize sustainable wealth management over aggressive financial engineering.
Disclaimer: The information contained in this article does not constitute investment advice. Investors should be aware that cryptocurrencies carry high volatility and therefore risk, and should conduct their own research.
